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Abstract 
 
Early life trauma leads to behavioural abnormalities later in life. These include 
mood and anxiety disorders such as depression and posttraumatic stress 
disorder (PTSD). This association may be due in part to the effects of trauma 
on brain development. Data from basic and clinical experiments suggest that 
alterations in the hippocampus may be fundamental to the development of 
these disorders.  
Here we used an animal model of early life trauma to investigate its effects on 
the behaviour and neurochemistry of the adult rat. Adolescent rats were 
subjected to time-dependent sensitization stress consisting of a triple stressor 
(2 hours restraint, 20 min swim stress and exposure to ether vapour) on post-
natal day (PND) 28, a single re-stress on PND 35 (20 min swim stress), and a 
second re-stress in adulthood (PND 60, 20 min swim stress). The rationale 
was that the frequency of exposure to situational reminders contributes to the 
maintenance over time of fear-related behavioural disturbances. The effects of 
trauma on the hypothalamus-pituitary-adrenal-axis, hippocampal and plasma 
neurotrophin levels, behaviour and phosphoinositide-3 kinase (PI-3 kinase) 
signaling proteins were initially investigated. In addition, proteomic 
technologies such as protein arrays and 2D-SDS PAGE combined with liquid 
chromatography tandem mass spectrometry (LC-MS/MS) were employed to 
study trauma-induced effects on the hippocampus.   
Traumatized animals showed a decrease in glucocorticoid receptors in the 
dentate gyrus of the hippocampus and an increase in basal corticosterone 
levels 24 hours after adulthood re-stress. These effects were reversed by 
pretreatment with the serotonin selective reuptake inhibitor, escitalopram. 
A decrease in the neurotrophins, BDNF and NT-3 were evident 8 days, but 
not 24 hours after adulthood re-stress. This decrease was not accompanied 
by decreases in plasma neurotrophin or PI-3 kinase, protein kinase B (PKB), 
phosphatase and tensin homologue (PTEN), phospho-forkhead and phospho-
AFX protein levels. In addition, traumatized animals showed increased rearing  
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in both the elevated plus maze and open field. Proteomic analysis of trauma-
induced changes in the hippocampus show increases in Ca2+ homeostasis / 
signaling proteins such as S-100B, phospho-JNK and calcineurin. Apoptotic 
initiator proteins, including caspase 9, -10 and -12 were increased and there 
was evidence of cytoskeletal protein dysregulation. Furthermore, cell cycle 
regulators and energy metabolism proteins were decreased. These effects 
indicate to a cellular state of cell cycle arrest after increased calcium influx to 
avoid apoptosis.  
Our data suggest that adolescent trauma with adulthood re-stress may affect 
numerous systems at different levels. These include neuroendocrine-, protein 
systems and behaviour, and confirmed that a systems biology approach is 
needed for a better understanding of the neurobiology of mental disorders. 
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Opsomming 
 
Vroeë lewens trauma kan lei tot patalogiese gedrag in die volwasse 
lewenstydperk. Hierdie gedrag sluit depressie en posttraumatiese stres 
steuring (PTSS) in. Die verband tussen trauma en patalogiese gedrag mag 
moontlik aangespoor word deur die effekte van trauma op breinontwikkeling. 
Resultate van basiese en kliniese eksperimente het aangetoon dat 
veranderinge in die hippokampus van kardinale belang is in die ontwikkeling 
van patalogiese gedrag.     
’n Diermodel vir vroeë lewens trauma is gebruik om die effekte op gedrag en 
neurochemie van die volwasse rot te bestudeer. Adolessente rotte was 
onderwerp aan tyd-afhanklike sensitisasie stres bestaande uit ’n drievoudige 
stres paradigma (2 ure immobilisasie, 20 min swem stres en blootstelling aan 
eter dampe) op lewensdag (LD) 28, ’n tweede swem sessie op LD 35 en ’n 
laaste swem sessie op LD 60. Die veronderstelling was dat die herhaalde 
blootstelling aan dieselfde soort stres lei tot die behoud van abnormale vrees 
gedrag oor ’n lang tydperk. Die effekte van trauma op die HPA-as, 
neurotrofien vlakke in die hippokampus en plasma, gedrag en PI-3 kinase 
seintransduksie proteïene was aanvanklik ondersoek. Verder is proteoom 
tegnologie waaronder proteïen “arrays” en 2D-SDS PAGE wat gekombineer 
was met kromatografie tandem massa spektrometrie gebruik om effekte van 
trauma op die hippokampus te bepaal.          
Getraumatiseerde diere het minder glukokortikoïed reseptore in die 
hippokampus en ’n verhoogde basale vlak van kortikosteroon in die plasma 
24 uur na volwasse (LD 60) swem stres vertoon. Hierdie effekte was 
omgekeer deur vooraf behandeling met die selektiewe serotonien heropname 
inhibitor, escitalopram.  
Die neurotrofiene, BDNF en NT-3, was nie 24 uur na volwasse swem stres 
verlaag nie, maar wel na 8 dae. Hierdie verlaging het nie saam met ’n 
vermindering in plasma neurotrofiene of PI-3 kinase, PKB, PTEN, fosfo-
forkhead en fosfo-AFX proteïenvlakke gepaard gegaan nie. Getraumatiseerde  
vi 
 
diere het verder ook meer hiperaktiwiteit in die “open field” en “elevated plus 
maze” vertoon. Analise van die trauma proteoom het ’n verhoging in kalsium 
homeostase en seintransduksie proteïene soos S-100B, fosfo-JNK en 
calcineurin in die hippokampus vertoon. Apoptotiese proteïen vlakke soos 
kaspase 9, -10 en -12 was verhoog en daar was bewyse van sitoskelet 
disregulering. Selsiklus reguleerders en energie metaboliese proteïene was 
verlaag in getraumatiseerde diere. Hierdie effekte dui op ‘n staat van selsiklus 
stagnering na verhoogde kalsium instroming om apoptose te verhoed.  
Ons resultate dui daarop dat adolessente trauma saam met stres in 
volwassenheid, verskeie sisteme op verskillende vlakke beïnvloed. Dit sluit in 
neuroendokrien-, proteïen sisteme en gedrag, en bevestig dat ‘n sisteem 
biologiese benadering nodig is om die neurobiologie van psigiatriese 
steuringe beter te verstaan.           
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Chapter 1 
Introduction to the study 
 
1.1 Introduction 
Studies have now clearly shown that early life stress leads to a number of 
behavioural abnormalities often exhibited later in life (Heim and Nemeroff, 
2001; Kendler et al., 1992). This is particularly true for mood and anxiety 
disorders, such as depression and posttraumatic stress disorder (PTSD). 
Imaging data from clinical experiments suggest that alterations in the 
hippocampus may be fundamental to the development of these disorders 
(Duman et al., 1997; Duman et al., 1999; McEwen, 1999). For instance, 
reduced hippocampal volume has recently been documented in patients 
diagnosed with depression (Neumeister et al., 2005) and PTSD (Kitayama et 
al., 2005). Support for the involvement of an aberrant hippocampus in the 
aetiology of these disorders comes from basic studies where animals, 
subjected to different stressors (physical, psychosocial, and prenatal 
stressors) show decreased hippocampal neurogenesis, that may contribute 
significantly to the  observed structural changes in the hippocampus (Czeh et 
al., 2002; Lemaire et al., 2000).  
Early life stress affects hippocampal neurotophin levels (Roceri et al., 2002) 
and since neurotrophins are growth factors important for the well-being of 
neurons, changes in their concentrations may be one mechanism by which 
prolonged stress exerts its deleterious effects. In addition, early adverse 
events impact negatively on the activity of the hypothalamus-pituitary-adrenal-
axis (HPA-axis) (de Kloet et al., 2003), hence one would naturally suspect an 
interaction between the two systems. However, there is contrasting evidence 
suggesting both the presence (Smith et al., 1995, Ueyama et al., 1997), as 
well as an absence (Aloe et al., 1994; Scaccianoce et al., 2000) of an 
interaction between the HPA-axis and neurotrophins.  
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1.2 Research objectives 
The aim of this study was therefore to characterise the long term effects of 
early life trauma and adulthood re-stress in an animal model. The study 
particularly focused on behaviour, HPA-axis activity and hippocampal protein 
expression. The efficacy of pharmacological treatment in the form of a 
serotonin selective reuptake inhibitor (SSRI) to reverse the anticipated effects 
was also investigated.  Standard methodologies as well as novel proteomic 
technologies were employed in this study.  
      
1.3 Research strategy 
After carefully studying the literature of animal models of anxiety disorders 
(chapter 2), it was decided to focus on the time dependent sensitization (TDS) 
model. Whilst the model has previously been used to study PTSD, we 
considered it appropriate for early life trauma.  
Firstly we addressed the impact of early life stress on HPA-axis activity, 
concentrating on basal corticosterone release and glucocorticoid receptors in 
the dentate gyrus of the hippocampus. This receptor location was chosen as it 
is one of the major sites for neurogenesis (Czeh et al., 2002). Stressed 
animals were also treated with the SSRI, escitalopram, in order to see 
whether stress-induced changes were reversible. These experiments are 
described in Chapter 3.   
Subsequently the effects of early life stress on hippocampal neurotrophin 
expression 24 hours after adulthood re-stress were investigated (Chapter 4). 
Results from these experiments indicated a dissociation between the HPA- 
axis and hippocampal neurotrophin levels. Alternatively, our data were 
interpreted as 24 hours being too early for any significant changes to occur at 
the level of neurotrophin expression. Following the latter reasoning, 
behavioural, HPA-axis and hippocampal neurotrophin expression were 
assessed 8 days post-adulthood re-stress. In addition, plasma neurotrophin 
were measured in the same animals to determine whether a correlation 
existed between brain and blood neurotrophin levels. The protein levels of 
members of the phosphoinositide-3 (PI-3) kinase signaling pathway were also 
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measured to see whether changes in ligand concentrations were translated to 
alterations in second messenger signaling (Chapter 5 and 6). 
In order to obtain a broader picture of the effects of early life trauma, a multi-
systems biological approach was adopted. An overview of current proteomic 
strategies and their application to human and animal anxiety disorder studies 
are therefore reviewed in chapter 7, while some of the techniques have been 
applied in our experiments. Chapter 8 subsequently presents data generated 
using protein arrays that has been complemented with additional proteomic 
methods - 2D-SDS PAGE combined with liquid chromatography tandem mass 
spectrometry (LC-MS/MS). In this study particular attention was given to the 
effects of early life trauma on ventral hippocampal protein expression, as 
neurotrophin alterations occurred in this brain area.   
 
1.4 Conclusion 
The present study aimed to delineate the effects of early life trauma and 
adulthood re-stress in the hope of identifying the underlying processes which 
contribute to the development of psychiatric disorders later in life. We have 
utilised the TDS / Re-stress model to investigate this phenomenon and 
obtained interesting results. On a macro level we demonstrated that early life 
trauma and adult re-stress can lead to behavioural and neuroendocrine 
abnormalities comparable to that observed in patients suffering from anxiety 
disorders. These abnormalities were associated with biochemical changes in 
the hippocampus that included changes in neurotrophin levels and 
glucocorticoid receptors. Pretreatment with escitalopram was able to reverse 
the neuroendocrine aberrations. However, proteomic analysis of the ventral 
hippocampus alone showed that a host of alterations occur within the protein 
profile following trauma. For instance increases in pro-apoptotic proteins were 
observed while the levels of regulators of the cell cycle were significantly 
decreased. Our study therefore underlined the intricacies of behaviour and 
therefore confirmed that the interplay of complex systems needs to be studied 
for a better understanding of the neurobiology of mental disorders.  
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Abstract 
Animal models may be useful in investigating the fundamental mechanisms 
underlying psychiatric disorders, and may contribute to the development of 
new medications. A computerized literature search (MEDLINE: 1981 – 2003) 
was used to collect studies on recently developed animal models for anxiety 
disorders. Particular cognitive-affective processes (e.g. fear conditioning, 
control of stereotypic movements, social submissiveness, trauma 
sensitization) may be particularly relevant to understanding specific anxiety 
disorders. Delineation of the phenomenology and psychobiology of these 
processes in animals leads to a range of useful models of these conditions. 
These models demonstrate varying degrees of face, construct, and predictive 
validity. 
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Introduction 
Animal models can potentially contribute to understanding the mechanisms 
underlying anxiety disorders, and to screening and developing new 
medications for their treatment [1; 2]. An initial focus of preclinical work was 
on the broad construct of “anxiety”, and in particular in addressing the issue of 
determining whether novel agents had anxiolytic properties [3; 4]. Barbiturates 
and benzodiazepines, for example, had anxiolytic properties in particular 
paradigms, and the efficacy of new molecules could be compared to these 
agents. This approach was, however, problematic insofar as it was not always 
based on specific cognitive-affective processes relevant to anxiety disorders, 
and insofar as it was unable to predict the value of various medications (e.g. 
antidepressants) for human anxiety disorders.  
 
Some models of anxiety have focused on changes associated with acute 
stress, while others have aimed at understanding the neurobiology of chronic 
stress (e.g. models of learned helplessness). Models of chronic stress 
arguably have applicability across a range of psychiatric conditions, including 
mood [5] and anxiety disorders [6]. Conversely, it has been argued that 
although these models have provided valuable insights about the 
neurochemistry and neuroendocrinology of stress responses, they have not 
led to insights into individual psychiatric disorders. The broad concept of a 
general stress response, arguably needs to be supplemented by more specific 
understanding of the mechanisms underlying particular cognitive-affective 
processes (eg fear conditioning) involved in particular anxiety disorders. 
 
Given the increased evidence that anxiety disorders may have distinctive 
symptomatology and neurobiology, specific cognitive-affective processes may 
be particularly relevant to each of the different anxiety disorders. Furthermore, 
although some of the anxiety disorders seem to be specific to humans, a 
number of these cognitive-affective processes can be studied in lower 
animals. This paper discusses models of generalized anxiety disorder (GAD), 
obsessive compulsive disorder (OCD), panic disorder (PD), social phobia (SP) 
and posttraumatic stress disorder (PTSD) [7], in each case emphasizing a 
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cognitive-affective process that may be especially relevant to that disorder. A 
computerized literature search (MEDLINE: 1981 – 2003) was used to search 
for studies on recently developed animal models for anxiety disorders. 
 
Generalized anxiety disorder (GAD) 
 
GAD is characterized by excessive and uncontrollable worries about life 
events. These worries are accompanied by motor tension or hypervigilance 
[7]. Clinical studies point to dysregulation of monoamine [8] and gamma-
aminobutyric acid (GABA) [9] neurotransmitter systems in GAD. 
Complementing these findings are clinical trials showing that GAD responds 
reasonably well to benzodiazepines, buspirone, and antidepressants [10]. 
 
Development of a behavioral model of GAD is complicated by the fact that 
core diagnostic criteria for GAD have changed over time [11].  GAD was 
originally conceptualized as a residual category, for patients’ whose anxiety 
symptoms did not meet criteria for other anxiety disorders.  Subsequent DSM 
definitions of GAD have increasingly focused on “worry”, a cognitive symptom 
that may not have a clear behavioral analogue.  Another way of 
conceptualizing GAD, however, is in terms of heightened activation of innate 
general avoidance behaviors [6]. 
 
General Avoidance Behaviors 
 
A number of animal models based on this principle have been developed. 
Amongst the best known is the elevated plus- maze (others include the open 
field test [12] and the stress-induced vocalization model [13]). In the elevated 
plus maze, a rat or mouse is placed in the center of a maze which has two 
open and two closed arms, and the animal is allowed to explore freely. The 
natural fear of open spaces is responsible for the reluctance to explore the 
maze and fear is measured by the decreased percentage time spent in an 
open-arm [3]. The elevated plus-maze is sensitive to anxiogenic and anxiolytic 
agents that act on GABA receptors [3] and to corticotropin releasing factor 
(CRF) receptor antagonists [14; 15]. 
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This model can be used to investigate a range of potential neurobiological 
dysfunctions relevant to GAD.  For example, mice lacking the 5-HT1A receptor, 
or 5-HT1A knock-outs (5-HT1A KO), show more anxious behavior in the 
elevated plus maze [16].  It was also found that diazepam proved anxiolytic in 
this paradigm, but the effects varied according to the mouse species [17; 18].  
Although the gross dysfunction produced by a KO model may differ from the 
more subtle dysfunctions seen in human psychopathology, KO’s have the 
advantage of being able to study the effects of a single genetic change.   
 
From a phenomenological perspective, it is unclear whether the elevated plus-
maze models the core symptom of GAD, i.e. excessive “worry”. Furthermore, 
the elevated plus-maze has a range of methodological problems. These 
include inter-laboratory differences, and differences between animal strains 
[19].  Finally, although benzodiazepines reliably reduce anxiety in the 
elevated-plus maze [3; 19], studies with 5-HT1A agonists and SSRIs have 
proven inconsistent [20]. This is in contrast to clinical studies that regularly 
demonstrate serotonergic anxiolytics to be effective in treating GAD [10].  
Given these limitations, preclinical work that is intended to address GAD may 
need to employ a combination of different behavioral models (eg EPM and 
OFT). 
 
Obsessive-compulsive disorder (OCD) 
 
OCD is characterized by obsessions (recurrent and persistent thoughts), and 
compulsions (repetitive behaviors or mental acts in response to obsessions) 
[7]. Clinical studies have emphasized the importance of cortico-striatal circuits 
in mediating OCD, and have supported the hypothesis that serotonin and 
dopamine play important roles in mediating the disorder [21; 22]. Selective 
serotonin reuptake inhibitors (SSRI’s) are currently the first-line choice of 
agent in the treatment of OCD [23] and patients refractory to these agents 
may respond to augmentation with dopamine blockers [24]. Auto-immuno 
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processes may play a role in the cortico-striatal dysfunction seen in some 
OCD patients [25]. 
 
Stereotypy is arguably central to OCD, since stereotyped behavior with its 
repetitive, topographically invariant movements is reminiscent of the 
compulsions of OCD. Animal models that focus on this phenomenon include 
the behavioral model of spontaneous stereotypy in deer mice [26; 27; 28; 29], 
veterinary disorders characterized by stereotypy such as acral lick dermatitis 
in canines [30], and a number of anatomical/molecular models of repetitive 
behavior [31; 32; 33] 
 
Control of Repetitive Movements 
 
In the rodent model of spontaneous stereotypy, deer mice (Peromyscus 
maniculatus bairdii) express patterns of motor behaviors that are repetitive, 
excessive and topographically invariant. These behaviors lack any obvious 
function and purpose [26; 27; 28; 29]. The patterns of motor behavior include 
patterned running, jumping and backward somersaulting. The DA-agonist, 
apomorphine, has been found to induce behaviors in non-stereotypic mice 
that are topographically distinct from behaviors emitted by stereotypic mice. 
Furthermore, apomorphine only increases two of the three stereotypic 
behaviors usually emitted by deer mice with no increase in DA receptor 
sensitivity. Thus, while DA dysfunction may underlie certain aspects of OCD, 
spontaneous stereotypy is only partially mediated by the dopamine system 
[27]. The role of the 5-HT system in mediating deermice stereotypy, and its 
response to administration of different agents, remains to be fully clarified. 
 
Acral lick dermatitis (ALD) is a veterinary disorder characterized by repetitive 
paw-licking and biting of the extremities in different mammalian species, 
particularly in large dogs. ALD therefore has some face validity as a model for 
OCD, insofar as both conditions can arguably be conceptualized as grooming 
disorders.  Furthermore, like OCD, ALD responds more robustly to serotonin 
reuptake inhibitors than to noradrenergic agents [30].  While the 
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phenomenology of ALD differs from some subtypes of OCD, stereotypic 
behaviors in other species are arguably reminiscent of such subtypes (eg 
rodent hoarding) [34].  Various stereotypies in other animals (eg primates) 
may also respond to SSRIs [35].  There is a need for additional research to 
delineate the neurobiological dysfunctions that underlie ALD, and to see 
whether these are analogous to those responsible for OCD.  
 
Dopamimetic agents such as dex-amphetamine and apomorphine, 
administered orally or injected into brain regions such as the striatum, have 
been extensively used to study the neurobiology of stereotypy [36; 37; 38]. 
For example, rats treated chronically with the dopamine D2/D3 receptor 
agonist, quinpirole, develop compulsive checking behavior [31; 32] and 
perform ritual-like behavioral acts at specific places in an open field. 
Interestingly, the SSRI clomipramine partially attenuates quinpirole-induced 
compulsive checking [31] suggesting at least a partial role for 5-HT in this 
behavior, and supporting the regulatory role of striatal 5HT on dopamine-
driven behaviors [22]. Although drug-induced stereotypy is only partly 
reminiscent of the phenomenology of OCD, it does appear to model some 
aspects of the neurobiology of this condition.   
 
Clinical research suggests that OCD and tics may be mediated by cortico-
striatal circuits. One possibility is that such dysfunction involves auto-immune 
processes [39], and in a preclinical model of this phenomenon, rats were 
injected with sera from Tourette's syndrome patients with high levels of 
autoantibodies in the ventrolateral striatum, an area associated with oral 
stereotypy [37]. Experimental animals exhibited significantly higher oral 
stereotypy scores (wood chip eating, self-gnawing, biting, licking not 
associated with grooming, and repetitive paw-to-mouth movements) 
compared to animals injected with sera from normal subjects or patients with 
Tourette's syndrome with low autoantibody titers [40]. Although there is 
evidence that certain immunotherapies may be useful in pediatric autoimmune 
neuropsychiatric disorders associated with streptococcal infections (PANDAS) 
[39], parallel preclinical data is not yet available.  This model has 
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phenomenological and neurobiological aspects reminiscent of OCD and 
deserves further study. 
 
Panic disorder (PD) 
 
PD is characterized by recurrent unexpected panic attacks followed by 
persistent concern about additional attacks, worry about the implications of 
the attack or its consequences and a significant change in behavior related to 
the attacks [7]. A panic attack is normally accompanied by a range of 
sympathetic symptoms and clinical studies suggest dysregulation of the 
noradrenergic [41; 42; 43] and serotonergic [44; 45] neurotransmitter systems. 
Patients with PD respond to various antidepressants including tricyclics 
(TCA’s), monoamine oxidase inhibitors (MAOI’s), and SSRIs, and to certain 
benzodiazepines [46].  
 
Fear conditioning and extinction are processes that may be relevant to the 
pathogenesis of a number of different anxiety disorders and their treatment 
[47].  Nevertheless, certain phenomena seen after fear conditioning, such as 
fear-potentiated startle, are reminiscent of the symptoms of panic disorder 
(and of the arousal symptoms of PTSD). In this section, we discuss how 
preclinical studies of fear conditioning may shed light on the neuoroanatomical 
and molecular basis of panic disorder.  
 
Fear Conditioning 
 
Animal models of conditioned fear examine behaviors that are provoked by 
stimuli associated with an aversive stimulus, for example an electric foot-
shock. Fear conditioning is therefore a form of Pavlovian conditioning where a 
neutral stimulus is paired with an aversive stimulus (unconditioned stimulus). 
After a number of pairings the neutral stimulus (conditioned stimulus) elicits 
fear behaviors without the presence of the aversive stimulus. A major advance 
has been the delineation of the role of the amygdala and other limbic 
structures in mediating innate and conditioned fear responses [48; 49; 50].  
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In animals, stimulation of the amygdala results in behavioral [51] and 
physiological [52] patterns associated with fear and anxiety, while stimulation 
of specific target areas of the amygdala produces more selective effects [50]. 
The extended amygdala may be particularly relevant to anxiety (rather than 
fear), and the hippocampus plays an important role in contextual fear 
conditioning.  Finally, medial prefrontal cortex (anterior cingulated) plays a 
crucial role in mediating the extinction of fear conditioned responses.  
Neurotransmitters that are crucial in this circuitry include the serotonergic, 
glutamatergic and GABAergic systems. 
 
The fear-potentiated startle response, which consists of fast muscle 
contraction, especially around the face, neck and shoulders [53], is arguably 
reminiscent of a panic attack. One of the regions that play an important role in 
the fear-potentiated startle response is the periaqueductal gray [54]. 
Stimulation of the dorsal periaqueductal gray (dPAG) elicits fear behaviors 
and autonomic arousal [55; 56] and lesions of the PAG prevent fear-
potentiated startle [57].  Fear-potentiated startle is sensitive to fear-modulating 
drugs, for example, benzodiazepine agonists [58], 5-HT1A agonists [59] and N-
methyl-D-aspartate (NMDA) receptor antagonists [60]. Panicogenic drugs, 
such as yohimbine and caffeine, lead to an increase in dPAG-induced 
aversion, while a number of anti-panic drugs, including clonazepam and 
alprazolam, lead to a decrease [55]. 
 
Fear conditioning appears relevant to understanding the development of 
agrophobia in patients with panic disorder, and arguably provides a 
conceptual foundation for an integrated approach to extinguishing fear by 
means of medication or desensitization. Although a fear-potentiated startle 
model is partly reminiscent of the phenomenology of PTSD, there is arguably 
overlap with the responses to impending danger also seen in PD [61]. Clinical 
studies of panic disorder indicate that the neurocircuitry of PD is broader than 
simply the dPAG. Nevertheless, the dPAG component of this model may have 
some predictive validity; like PD it responds to clonazepam and alprazolam, 
imipramine and fluoxetine [62]. 
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There is increasing evidence for a function of amygdala glutamate receptors 
in fear learning, fear-potentiated startle, and fear extinction [50; 63]. More 
specifically, amygdala NMDA receptors appear to be involved in the neural 
changes that support fear learning and also loss of fear that accompanies 
extinction training [64]. For example, mice lacking a fully functional glutamate 
NMDA receptor have been found to be less sensitive to stress induced by the 
elevated plus-maze, light-dark box, and forced swimming tests [65]. Amygdala 
(±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors 
also participate in fear learning [66], and glutamate metabotropic group II 
receptor agonists block fear learning as well as fear-potentiated startle [67].  
 
Augmentation of traditional antidepressants with NMDA antagonists in various 
animal models of stress and depression [68], and their ability to re-establish 
anti-stress efficacy after antidepressant withdrawal [69], hints at the potential 
of future treatment strategies with glutamatergic agents  [70; 71]. 
Nevertheless, there is to date limited evidence for the role of glutamate in PD 
and for the efficacy of NMDA-antagonists in the treatment of this disorder.  
 
Social Phobia 
 
Social phobia is characterized by excessive fear of social and performance 
situations. Patients may experience panic attacks in such situations, and tend 
to avoid them [7]. Patients with social phobia respond to SSRI’s [10], 
suggesting an involvement of the serotonin system, although there is also 
evidence from clinical studies of dopaminergic involvement [72]. 
 
Some authors have suggested that social phobia is a uniquely human 
condition.  Nevertheless, social submissiveness is seen in lower animals, and 
may constitute a cognitive-affective process that proves useful for studying the 
neurobiology of social phobia. 
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Social Submissiveness 
Social submissiveness has been a particular focus of attention in studies of 
non-human primates.  For example, social status and degree of social 
affiliation are associated with altered HPA-axis function among free-ranging 
wild baboons [73]. Socially subordinate baboons exhibit hypercortisolism and 
resistance to feedback inhibition after dexamethasone treatment. 
Nevertheless, it is unclear that social phobia is characterized by HPA-axis 
dysfunction [74]. 
 
Lower social status in monkeys is, however, associated with lower dopamine 
D2 striatal receptor density [75], a finding that is consistent with clinical 
research on social phobia [76]. Furthermore, social submissiveness in non-
human primates decreases in response to administration of SSRIs [77]. These 
kind of data lend support to the thesis that social phobia can be 
conceptualized in terms of an appeasement display [78]. 
 
Posttraumatic stress disorder (PTSD) 
 
PTSD develops after an individual has experienced or witnessed a life-
threatening traumatic event. The symptoms include re-experiencing the 
traumatic event (for example flashbacks and nightmares), generalized 
arousal, and avoidance of stimuli associated with the trauma [7]. Clinical 
studies have implicated the amygdala and hippocampus [79], and have 
demonstrated enhanced negative feedback of the HPA-axis [80] and 
dysregulation of catecholamine neurotransmitter systems [81]. Patients 
diagnosed with PTSD respond to a range of medications, including TCAs, 
MAOIs, and SSRI’s [10]. 
 
Animal models of PTSD have utilised intense stressors, aversive challenges, 
and situational reminders of a traumatic stress, in an attempt to model long-
term effects on behavioral, autonomic, and hormonal responses seen in 
humans with PTSD. Examples include electric shock [82], stress–restress or 
time-dependent sensitization (TDS) [83], underwater trauma [84], and 
exposure of animals to a predator [85; 86]. Models of early developmental 
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trauma [87; 88] may also be relevant to understanding PTSD. We will focus 
here on the process of time-dependent sensitization. 
 
Time-dependent sensitization (TDS) 
 
The behavioral model of stress-restress or time dependent sensitization (TDS) 
has been proposed as a useful model for PTSD [89]. In this model, animals 
are exposed to single session of prolonged stress (eg, 2hr restraint followed 
by a 20 minute forced swim, followed by exposure to ether or halothane 
vapors). The animals are allowed to recover for a week, whereafter they are 
subjected to a brief restress on day 7 (30 minutes of restrain stress or 20 
minutes swim stress). The rationale being that the frequency of exposure to 
situational reminders contributes to the maintenance over time of fear-related 
behavioural disturbances. 
 
The model has proved valuable for studying HPA abnormalities relevant to 
PTSD [83]. Animals subjected to TDS display the enhanced sensitivity to 
negative glucocorticoid feedback that is characteristic of PTSD. In addition 
stress-restress evokes significant spatial memory deficits together with 
lowered plasma corticosterone, again consistent with clinical findings [90]. 
Stress-restress leads to changes in hippocampal 5HT1A and pre-frontal cortex 
5HT2A receptors [90], brain areas that are intimately involved in memory and 
stress responsiveness. 
 
From a phenomenological and biological perspective the TDS model 
emphasizes the role of prior trauma in predicting subsequent dysfunction, 
allows for the study of bidirectional expression of symptoms (enhanced or 
reduced responsiveness to environmental stimuli), and provides credible intra-
subject variation [89]. Interestingly, TDS-induced stress effects on spatial 
memory are attenuated by both fluoxetine, and by the steroid synthesis 
inhibitor, ketoconazole [91].  Moreover, in line with the increasing evidence for 
an involvement of glutamatergic mechanisms in the pathology and 
pharmacology of stress and anxiety [70; 71], it is of interest that stress-
restress evokes a significant increase in hippocampal nitric oxide synthase 
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activity, together with marked changes in hippocampal NMDA receptors [92]. 
The efficacy of other anti-PTSD agents in the TDS model still remains to be 
proven. 
 
With advances in genomics, it will be increasingly possible to explore the 
specific genetic basis of individual differences in processes such as TDS, and 
susceptibility to PTSD [93].  A genetic animal model of congenital learned 
helplessness (cLH), for example, has been used to explore the role of genetic 
predisposition in PTSD [94]. The first cLH breeding line was selected by 
subjecting out-bred Sprague-Dawley rats to random electric foot-shocks. 
Twenty-four hours later the animals were tested in a shock-escape paradigm 
where foot-shock could be eliminated by a single bar press. Failure to 
eliminate the shock in 20 seconds counted as a failed trail. Rats scoring 11-15 
failed trials in a 15-trial session were labeled cLH. Animals from the 33rd 
breeding line of cLH animals were monitored for changes in pain tolerance, 
spatial memory and hypothalamic-pituitary-adrenal function after re-exposure 
to intermittent stress.  Stress-induced analgesia was significantly increased in 
cLH animals. cLH animals also exhibited significant deficits in spatial memory 
as measured by the Morris water maze. In addition cLH animals exhibited 
HPA-hyporesponsitivity to major stressors possibly due to enhanced negative 
feedback sensitivity [94]. A decrease in pain sensitivity [95], impairment in 
memory [96], and enhanced negative feedback sensitivity [80] are all features 
of PTSD. Further work is needed to determine whether such animals are more 
at risk for developing adverse consequences after TDS, and whether 
pharmacotherapy is effective in reversing dysfunctions in cLH animals. 
 
 
Conclusions 
 
There is a growing understanding of the phenomenology and psychobiology 
of specific cognitive-affective processes (eg fear conditioning, social 
submissiveness, trauma sensitization) that may be relevant to the anxiety 
disorders.  While some of these processes are relevant to several different 
anxiety disorders, others (eg control of stereotypic behaviors) are particular 
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pertinent to specific conditions.  Although cognitive-affective processes in 
humans may have unique attributes, it is possible to study such processes in 
lower animals. 
 
Indeed, such work has led to a number of animal models of anxiety that 
demonstrate varying degrees of face, construct, and predictive validity 
(summarized in Table 1). These models have broadened our understanding of 
the neuroanatomy and neurochemistry of anxiety disorders, highlighting 
regions such as the amygdala and hippocampus, and systems such as 
serotonergic and glutamatergic circuitry. In the future, as new technologies 
become available to explore the precise molecular and genetic bases of 
cognitive-affective processes relevant to anxiety disorders, we can expect 
further progress. Ultimately, such work may lead to the development of novel 
treatment approaches.   
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Table 1: Cognitive-affective processes relevant to the molecular and 
anatomical basis of anxiety disorders, as modelled by various pre-clinical 
models of anxiety 
 
Disorder Cognitive Affective 
Process 
Paradigm Anatomy Molecular 
GAD General avoidance 
behaviors  
Elevated plus- 
maze 
Poorly defined 5-HT, GABA  
OCD Control repetitive 
movements 
Spontaneous 
stereotypy 
(deermice), 
ALD (canines), 
Drug-induced 
stereotypy 
Cortico-striatal 
circuits 
5-HT, DA, auto-
immune 
PD Fear conditioning Fear potentiated 
startle 
Amygdala, 
hippocampus, 
medial prefrontal 
cortex, dPAG 
5-HT, glutamate, 
GABA 
SP Social submission 
 
Primate hierarchy Amygdala, 
cortico-striatal 
circuitry 
5-HT, D2  
PTSD Time-dependent 
sensitization 
Rodent TDS 
model 
Hippocampus, 
prefrontal cortex 
HPA-axis, 5-HT,  
Refer to text for abbreviations and further description 
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Abstract 
 
Early exposure to adverse experiences may lead to specific changes in 
hippocampal glucocorticoid (GC) function resulting in abnormalities within the 
hypothalamic-adrenal (HPA) axis. Given interactions between the 
neuroendocrine and central serotonergic systems, we hypothesized that 
exposure to early trauma would lead to abnormal HPA axis activity that would 
be normalised by pretreatment with a serotonin selective reuptake inhibitor 
(SSRI). HPA axis function was assessed by determining basal corticosterone 
levels and hippocampal glucocorticoid receptor immunoreactivity. Rats were 
subjected to a triple stressor on post-natal day (PND) 28, and again to a 
single swim re-stress session on PND 35 and PND 60. On PND 61 i.e. 24 
hours after the last re-stress, tail-vein blood was collected for serum 
corticosterone determinations and hippocampal tissue was collected for 
immunohistochemistry of GC receptors. Escitalopram (5mg/kg) or saline 
vehicle was administered from PND 47 – PND 60 via osmotic mini-pumps. 
Animals exposed to early life trauma showed an increase in basal 
corticosterone levels, and a significant decrease in the ratio of GC receptor 
positive cells to total cells in the hilus, granule cell layer and the dentate gyrus. 
Both the increase in basal corticosterone and decrease in GC receptor 
imunoreactivity were reversed by escitalopram pretreatment. These data 
confirm alterations in HPA axis function that may stem from decreases in GC 
receptor levels, in response to early adverse experiences, and demonstrate 
that these alterations are reversed by SSRI pretreatment.  
 
Keywords: 
trauma, hippocampus, corticosterone, SSRI, immunohistochemistry 
 39
 
 
It has been suggested that the association between early life trauma and later 
psychopathology (Heim and Nemeroff, 2001; Kendler et al., 1992) is mediated 
by specific effects on hippocampal plasticity (Kaufman et al., 2000). Preclinical 
and clinical studies provide evidence for trauma-induced atrophy and loss of 
hippocampal neurons (Duman et al., 1997, 1999; McEwen et al., 1999). For 
example, brain-imaging studies indicate that hippocampal volume is reduced 
in disorders associated with early trauma, such as depression and 
posttraumatic stress disorder (Drevets, 2003; Grossman et al., 2002; Hull, 
2002). Given the stress-induced down-regulation of glucocorticoid (GC) 
receptors and glucocorticoid receptor mRNA (Kim et al., 1999; Ladd et al., 
2004; Workel et al., 2001), it has been proposed that changes in hippocampal 
structure may in fact be mediated by glucocorticoids. (Czeh et al., 2002; 
Lemaire et al., 2000; McEwen, 2000). 
 
Antidepressants also have actions on glucocortioid (GC) receptor expression. 
For example, in cultured rat primary hippocampal cultures, citalopram (Hery et 
al., 2000) increased GC receptor binding sites. However some in vivo studies 
showed changes in GC receptor expression after treatment with a selective 
serotonin re-uptake inhibitor (SSRI) (Brady et al., 1992; Yau et al., 2002), 
while others found no differences (Bjartmar et al., 2000; Budziszewska et al., 
1994). Interestingly, chronic in vivo treatment with the antidepressants, 
fluoxetine and reboxetine, increased neurogenesis in the adult hippocampus 
of normal animals (Malberg et al., 2000). On the other hand, stress-induced 
changes in hippocampal neurogenesis were prevented by prior treatment with 
the antidepressant tianeptine (Czeh et al., 2001).These studies therefore 
indicate that the effects of antidepressants on hippocampal biology remains 
unclear. 
 
Escitalopram,  the S-enantiomer of the SSRI citalopram, has proved to be 
effective in preclinical models of depression and anxiety, and was more potent 
than its racemate in inhibiting 5-HT transporter functions, 5-HT neuronal firing 
in the dorsal raphe nucleus and in potentiating 5-hydroxytryptophan-induced 
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behaviours (Sanchez et al., 2003). The present study therefore evaluated the 
effects of early life trauma combined with adulthood re-stress on HPA axis 
activity, GC expression in the hippocampus and examined the capacity of 
escitalopram to reverse the trauma-induced changes. We hypothesized that 
HPA axis function would be altered, GC receptor immunoreactivity in the 
hippocampus would be reduced in rats subjected to early life trauma, and that 
14 days of pretreatment with escitalopram would reverse these effects. 
 
Experimental Procedures 
 
Animals 
The animal studies were approved by the ethics committee of the University of 
Stellenbosch. All experiments conformed to the Helsinki convention for the 
use and care of animals. Care was taken to minimize the number of animals 
and their suffering. Male Sprague-Dawley rats were used. Animals were 
housed in pairs under standard laboratory conditions (12/12 hours light/dark 
cycle, food and water ad libitum) in the central animal research facility of the 
University of Stellenbosch. 
Animals were divided into four experimental groups: control + vehicle, control 
+ escitalopram, trauma + vehicle and trauma + escitalopram.  A total of 54 
animals were used, 21 of these animals were randomly selected for 
immunohistochemistry.  
  
Trauma procedure 
The trauma procedure is based on the TDS model where animals are 
subjected to a single exposure of sequential stressors of escalating severity 
followed by a single exposure to one of the stressors, 7 days later (Liberzon et 
al., 1997; Yehuda and Antelman, 1993; Harvey et al, 2003). The rationale is 
that the frequency of exposure to situational reminders contributes to the 
maintenance over time of fear-related behavioural and neurochemical 
disturbances. Young rats were subjected to a triple stressor on PND 28.  The 
triple stressor consisted of being firstly placed in a plexiglass restrainer for 
2hrs with the tail-gate adjusted to keep the rat well contained without impairing 
circulation to the limbs; secondly the rats were placed individually in 18 cm of 
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ambient water (25°C) in a perspex swim tank and forced to swim for 20 
minutes; and finally after gently drying the rat with a soft towel and 30 minutes 
recovery, each rat was then exposed to ether vapours until loss of 
consciousness. The animals were then removed and placed in their home 
cages.  
Traumatized animals were exposed to situational reminders by subjecting 
them to swim stress on PND 35 and again during adulthood on PND 60.  
 
Escitalopram treatment 
Escitalopram (5mg/kg, kindly donated by H. Lundbeck A/S, Copenhagen, 
Denmark) or saline vehicle was administered for 14 days (PND 47 – PND 60) 
via osmotic mini-pumps (ALZET, Cupertino, CA, USA. model 2ML2), 
implanted subcutaneously on PND 46. Animals were anesthetized with 
Equithesin mixture (pentobarbitone 6% and 0.25M chloral hydrate) and placed 
on a heating pad during surgery to prevent hypothermia. After implantation 
two animals were placed per cage with a clear, perforated Perspex divider 
between them, creating two compartments. This allowed the animals to 
exchange olfactory, visual and auditory cues without inducing total isolation 
stress. The divider prevented the animals from physically reaching each other 
and possibly dislodging the sutures of the mini-pump or injures its co-
inhabitant. After surgery the cage was placed under a heating lamp to again 
prevent hypothermia, until the animals were fully recovered. 
 
Corticosterone determination 
On PND 61 i.e. 24 hours after the last swim stress, serum and hippocampal 
tissue samples were collected for corticosterone determination and GC 
immunihistochemistry respectively. Blood was collected under Equithesin 
anesthesia via tail snip on PND 61 in prechilled 1.5ml Eppendorf tubes. All 
blood samples were collected between 9.00 and 11.00 am.  After collection 
blood samples were centrifuged (5 minutes, 14000 rpm, 4oC) and serum 
samples were stored in liquid nitrogen until measurement. Serum 
corticosterone (CORT) was measured using commercially available RIA kits 
(IBL, Germany).  
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Immunohistochemistry 
While the animals were deeply anesthetized, they were perfused 
transcardially with 100 ml ice cold saline followed by 500 ml fixative containing 
4% paraformaldehyde in 0.1 mol/L phosphate-buffered saline (PBS; pH 7.4) 
on PND 61. After perfusion the brains were removed, stored in fixative at 4oC 
overnight and transferred into 30% sucrose at 4oC for 24 hours and thereafter 
frozen at –800C until sectioning. 
A cryostat was used to collect serial coronal sections (30 μm) through the 
hippocampus (plates 26 – 40, Paxinos and Watson, 1986). Every 10th section 
was selected for immunohistochemistry. All sections were mounted and coded 
before processing to ensure objectivity.       
For glucocorticoid receptor (GR) peroxidase staining, sections were heated in 
a microwave for 5 minutes (100W) in sodium citrate buffer, cooled down for 5 
minutes, heated again (100W) for 10 minutes, cooled down for 20 minutes 
and finally rinsed in distilled water. This was followed by extensive washing in 
PBS, preincubated for 10 min in 3% H2O2 (to block endogenous peroxidases). 
Then the sections were preincubated for 1 h with PBS containing 0.5% 
Tween-20 and 1% bovine serum albumin (BSA), and subsequently incubated 
for 24 h at 40C in rabbit polylonal anti-GR antibody (1:50; Santa Cruz) diluted 
in PBS containing 0.5% Tween-20 and 1% BSA. The sections were then 
incubated for 30 min with a biotin-labeled horse anti-rabbit/mouse antibody 
(Dako LSAB 2 Universal kit) followed by amplification with an avidin-biotin 
complex (Dako LSAB 2 Universal kit) and visualized with DAB (Dako LSAB 2 
Universal kit).  
Slides were counterstained with hematoxylin, dehydrated, cleared and 
mounted with a coverslip under permanent mounting media (Dako). 
For GR immunofluorescence, sections were heated in a microwave for 5 
minutes (100W) in sodium citrate buffer, cooled down for 5 minutes, heated 
again (100W) for 10 minutes, cooled down for 20 minutes and rinsed in 
distilled water. This was followed by extensive washing in PBS, preincubation 
of 1 hour in PBS containing 0.5% Tween-20 and 1% BSA. Sections were then 
incubated for 24 h at 4 0C with rabbit anti-GR (Santa Cruz, 1:50) and mouse 
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anti-NeuN (Chemicon, 1:100) diluted together in PBS containing 0.5% Tween-
20 and 1% BSA. 
The sections were rinsed in PBS and incubated for 1 h in the dark at room 
temperature with goat anti-mouse Alexa 594 and goat anti-rabbit Alexa 488 
(both highly cross absorbed, 1:200, Molecular Probes) diluted together in PBS 
containing 0.5% Tween-20 and 1% goat serum. Slides were rinsed, dried and 
covered under Prolong Gold anti-fade reagent (Molecular Probes).  
 
Glucocorticoid receptor quantification  
Cells were examined under 40 x magnification with a Zeiss microscope and 
Zeiss KS300 image analyser and processed with Zeiss 3.0 software. Five 
sequential coded slices per animal were examined for GR positive cells in the 
right dentate gyrus (i.e. slide number 31, 41, 51, 61, 71). All GR positive cells 
within the hilus were counted regardless of size and shape. In addition, all GR 
positive cells in two randomly chosen areas in the granule cell layer were 
counted regardless of size and shape (see figure 1 for areas selected in each 
section).  
GR positive cells within the subgranular zone that were within two cell body 
widths of the granule cell layer were considered part of the granule cell layer. 
Total number of GR positive cells in the dentate gyrus (granule cell layer + 
hilus) and hilus or granule cell layer alone were expressed as a ratio of the 
number of positive cells to total cells (stained with hematoxylin) in a given 
area.  
 
Glucocorticoid receptor immunofluorescence 
In each animal co-localization of GR positive cells with neurons were 
examined using a Nikon fluorescence microscope under 20 x magnification.    
 
Statistical analysis 
Statistical analyses were done by the Centre for Statistical Consultation at the 
University of Stellenbosch. The data was analyzed with a one way ANOVA 
with SPSS version 11.0. When significant differences were obtained, post-hoc 
comparisons were performed using the LSD test. Data was considered 
significant if p ≤ 0.05.  
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Figure 1: Areas (one in the hilus and two in the granule cell layer) selected in 
the right dentate gyrus for glucocorticoid receptor immunoreactivity of 
traumatized and control animals. 
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Results 
 
Corticosterone levels 
There was an overall significant effect in basal corticosterone levels between 
the groups [F(3, 50) = 5.553, p ≤ 0.01] (figure 2). Traumatized animals treated 
with escitalopram did not differ significantly from saline controls (p = 0.38), but 
showed a decrease in corticosterone compared to traumatized animals 
treated with saline (p ≤ 0.01). Furthermore, traumatized animals treated with 
saline displayed an increase in basal corticosterone levels compared to saline 
treated controls (p ≤ 0.05). Control animals treated with escitalopram did not 
differ significantly from saline controls (p = 0.15). 
 
Immunohistochemistry 
GC receptor staining showed significant changes in GC receptor density in the 
granule cell layer. Animals that were exposed to trauma (figure 3a) exhibited 
diminished GC receptor positivity compared to controls (figure 3b). 
Traumatized animals treated with escitalopram (figure 3c) showed similar GC 
receptor positivity as saline controls (figure 3b). These observations were 
confirmed by our quantification methods (see below).  
 
Glucocorticoid receptor quantification 
There were overall significant effects between groups. Similar results were 
obtained for the hilus [F(3,17) = 4.647, p ≤ 0.05], granule cell layer [F(3,17) = 
5.778, p ≤ 0.01] and the dentate gyrus [F(3,17) = 5.842, p ≤ 0.01]. 
Traumatized animals treated with saline showed a decrease in the ratio of GC 
receptor positive cells/total cells compared to  saline controls in the hilus (p≤ 
0.01), the granule cell layer (p≤ 0.01) and the dentate gyrus (p≤ 0.01). These 
decreases were reversed by escitalopram pretreatment in all three areas and 
did not differ from saline controls; hilus (p = 0.54), granule cell layer (p = 0.37) 
and dentate gyrus (p = 0.38) [figures 4a, 4b and 4c]. Interestingly, control 
animals treated with escitalopram also displayed significant decreases in the 
ratio GC receptor positive cells/total cells compared to saline controls in the 
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hilus (p ≤ 0.05), granule cell layer (p ≤ 0.01) and dentate gyrus (p ≤ 0.01) and 
did not differ from traumatized animals treated with saline; hilus (p = 0.61), 
granule cell layer (p = 0.96) and dentate gyrus (p = 0.79).   
 
Glucocorticoid receptor immunofluorescence 
In our investigation as to the position of GC receptors, we found a high degree 
of co-localization of GC-receptor positive cells with neurons (figures 5).   
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Figure 2: Serum corticosterone levels of control and traumatized animals with 
or without escitalopram treatment. Values are expressed as mean ± SEM in 
ng/ml. Traumatized animals were subjected to a triple stressor on PND 28 
(restraint stress, swim stress and ether inhalation), and to swim stress alone 
on PND 35 and PND 60. Blood was collected form the tail vein on PND 61. 
Escitalopram treatment was administered via osmotic pumps from PND 47-61 
at a dose of 5 mg/kg. * p ≤ 0.05, control saline vs. trauma saline. ** p ≤ 0.01, 
trauma saline vs. trauma escitalopram 
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Figure 3a:      Figure 3b:    
   
     
Figure 3c:      Figure 3d:  
    
 
Figure 3: Representative photomicrographs of GC receptor immunoreactivity 
in the granule cell layer of traumatized (a), control (b), traumatized + 
escitalopram-treated (c) and control + escitalopram-treated (d) animals. 
Photomicrographs show traumatized animals having decreased GC receptor 
immunoreactivity compared to controls (a vs b), while traumatized + 
escitalopram-treated animals show no differences compared to controls (c vs 
b).  
(Scale bar in above figures 1cm = 30 μm) 
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Figure 4b:  
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Figure 4: Histograms depicting the ratio of glucocorticoid receptor positive 
cells to total cells in the hilus (a), granule cell layer (b) and dentate gyrus (c) of 
traumatized animals. *p ≤ 0.05, ** p ≤ 0.01.  
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Figure 5a:      Figure 5b:  
  
Figure 5c:  
 
 
Figure 5: Photomicrographs showing anti-NeuN labeled cells (a) in the 
dentate gyrus demonstrating immunoreactivity in the hilus and granule cell 
layer throughout, anti-GC receptor labeled cells (b) showing GC reactive cells 
in the dentate gyrus, and anti-NeuN and anti-GC receptor labeled cells 
merged (c) to demonstrate co-localization of neurons and GC receptor 
immunoreactivity in the dentate gyrus 
(Scale bar 1cm = 50 μm) 
 51
 
Discussion 
The main findings of the present study were that early life trauma 1) alters 
HPA axis function, 2) leads to changes in GC receptor immunohistochemistry 
in the hippocampus as reflected by decreased GC receptor immunoreactivity 
in the hilus, granule cell layer and dentate gyrus, and 3) that these changes 
could be reversed by pretreatment with the SSRI, escitalopram.   
 
The reduction in glucocorticoid receptor immunoreactivity as observed in 
animals that were subjected to early life trauma, is in accordance with studies 
demonstrating early life stress to decrease glucocorticoid receptor mRNA in 
adulthood (Kim et al., 1999; Ladd et al., 2004; Workel et al., 2001). A 
decrease in hippocampal glucocorticoid receptors implies decreased negative 
feedback inhibition of the HPA axis, resulting in higher levels of circulating 
corticosterone (Vasquez et al., 1996; Yehuda, 2001). This is in agreement 
with the corticosterone results found in this study. It is important to note that 
no significant differences in total cell count per area between the groups (data 
not shown), and therefore the differences in immunoreactivity were 
considered related to changes in GC receptor expression and not to loss in 
cell number per se. 
 
In the early life traumatized animals the decrease in glucocorticoid receptor 
immunoreactivity was effectively blocked by escitalopram (14 days, 
5mg/kg/d). That these beneficial effects of the drug strongly involve the 
serotonergic system is very likely (Sanchez et al., 2004), given recent 
evidence that trauma-induced neuroreceptor and memory changes can be 
modified by serotonin enhancing and depleting drugs (Harvey et al, 2004). In 
support, long-term exposure to high circulating levels of glucocorticoids 
following repeated trauma, attenuate 5HT levels in the hippocampus, thereby 
effectively removing 5-HT1A receptor-mediated inhibition of the hippocampus 
(Karten et al, 1999). The fact that chronic administration of escitalopram 
reversed a putative hyposerotonergic state induced by the trauma, and that 
both the elevated basal corticosterone levels and the reduction in GC 
immunoreactivity were normalized by this treatment, reaffirms a causal role of 
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altered 5-HT in this response. Such a mechanism is plausible as increased 
serotonergic activity following SSRI administration has been shown to restore 
HPA axis malfunction and glucocorticoid release via 5-HT1A receptors 
(Cassano and D’Mello, 2001). 
  
While it has been shown that escitalopram is effective in reducing ultrasonic 
vocalizations in maternally separated mouse pups, indicating anxiolytic effects 
(Fish et al., 2004), this is the first study to demonstrate escitalopram to 
prevent GC receptor expression in the hippocampus of an animal model of 
early life trauma. Another interesting finding is that control animals treated 
with escitalopram also showed reductions in GC receptor immunoreactivity in 
the hilus, granule cell layer and dentate gyrus, similar to traumatized controls. 
To our knowledge, there is no data on the effects of chronic escitalopram 
treatment on GC receptor expression in the hippocampus of normal control 
subjects. However some work has been performed with the racemate, 
citalopram. For instance animals treated with citalopram (20mg/kg/d) for 14 
days, showed no differences in GC receptor mRNA expression (Seckl and 
Fink, 1992) and 21 day treatment did not modify binding parameters of GC 
receptors in the rat hippocampus (Budziszewska et al., 1994). It has however, 
been reported that citalopram induced an increase in GR binding sites in 
cultured rat primary hippocampal cultures (Hery et al., 2000).  
 
There is limited data available on chronic escitalopram treatment in healthy 
human subjects. Acute administration of escitalopram (10mg) to healthy 
human subjects resulted in an increase in salivary and plasma cortisol levels 
(Nadeem et al., 2004). Chronic treatment of healthy human subjects with 
another SSRI, fluoxetine, resulted in no changes in mood (Gelfin et al., 1998) 
or cerebral blood flow (Bonne et al., 1999). These observations reveal that the 
effects of both acute and chronic antidepressants in healthy subjects remain 
controversial. 
 
In summary, early life trauma caused an elevation in basal corticosterone 
secretion that was associated with decreased glucocorticoid receptor 
immunoreactivity in the hilus, granule cell layer and dentate gyrus of the 
 53
hippocampus. These changes were prevented by escitalopram pretreatment, 
indicating interactions between the neuroendocrine and the serotonergic 
system. Future work is needed to delineate the exact nature of this interaction.  
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immunoreactivity in the rat dentate gyrus following 
adulthood re-stress and is reversed by escitalopram 
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Purpose of study: Early exposure to traumatic experiences may lead to 
specific changes in hippocampal glucocorticoid (GC) function, which is 
especially observable during adult re-stress. Given interactions between GC 
receptors, neurotrophins, and the serotonin system, we hypothesized that 
after exposure to early trauma, neurotrophin levels would decrease in 
response to re-stress, and that pre-treatment with escitalopram, a selective 
serotonin reuptake inhibitor (SSRI) antidepressant, would normalize GC 
receptor immunoreactivity in response to re-stress.  
 
Methods: Animals were subjected to a triple stressor (2 hours restraint, 20 min 
swim stress and exposure to ether vapour) on post-natal day (PND) 28, a 
single re-stress on PND 35 (i.e. time dependent sensitization (TDS) model), 
and a second re-stress in adulthood (PND 60). Hippocampal tissue was 
collected 24 hours post adulthood re-stress (second re-stress) for 
immunohistochemistry of GC receptors and analysis of brain derived 
neurotrophic factor (BNDF), nerve growth factor (NGF) and neurotrophin 3 
(NT-3) levels by ELISA. Escitalopram (5mg/kg) and saline vehicle was 
administered from PND 47 - PND 60 via osmotic mini-pumps.  
 
Results: Animals exposed to early life trauma showed no differences in NGF, 
BDNF or NT-3 (see figure 1a, 1b and 1c) in dorsal or ventral hippocampus 
compared to controls 24 hours post adulthood re-stress (second re-stress). 
However, there was a significant overall effect between groups at this time in 
glucocorticoid (GC) receptor immunoreactivity in the hilus [F(3,21) = 4.647, p 
=.015], granule cell layer [F(3,21) = 5.778, p = .007] and dentate gyrus 
[F(3,21) = 5.842, p = .006]; TDS animals showed a decrease in GC receptor 
positivity compared to controls in the hilus (p =.007), granule cell layer (p = 
.004) and dentate gyrus (p = 003). TDS animals treated with escitalopram 
showed an increase in GC receptor positivity compared to TDS animals 
treated with saline in the hilus (p = .018), granule cell layer (p = .023) and 
dentate gyrus (p = .016), to the extent that measures were similar to those 
seen in non-traumatized controls.  
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Conclusion: These data are consistent with previous work showing decreases 
in hippocampal GC receptor levels in response to early trauma, and with work 
showing that SSRIs act to increase GC receptor levels. The data confirm our 
hypothesis that decreases in GC receptor immunoreactivity in the 
hippocampus following early traumatic experience are reversed by 
escitalopram pretreatment. Additional delineation of the interactions between 
signal transduction proteins of GC receptors, neurotrophins and the 
serotonergic system is required. 
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Figure 1: Histograms depicting (a) NGF-, (b) BDNF-, and (c) NT-3 protein 
concentrations in the dorsal and ventral hippocampus of control and 
traumatized animals. Values are expressed as mean ± SEM (n = 20) in pg/mg 
wet weight. * p ≤ 0.05. 
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Abstract 
Effects of early life trauma on adult behavioral responses, corticosterone 
concentration and levels of nerve growth factor, brain-derived neutrophic 
factor and neurotrophin-3 in hippocampus and frontal cortex were 
investigated. Traumatized animals showed an increase in rearing in both the 
elevated plus maze and open field after adult re-stress,  higher basal levels of 
corticosterone, lower levels of BDNF in dorsal hippocampus, and lower levels 
of NT-3 in  dorsal- and ventral hippocampus. Trauma related behavioral 
hyperarousal and altered HPA axis activity may be mediated by decreases in 
hippocampal neurotrophin expression. 
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Introduction 
 
Early adverse experiences are known to be associated with later 
psychopathology, especially depression and anxiety disorders.1 This 
association may be mediated by specific effects of early stressors on brain 
development. In particular, preclinical and clinical studies have suggested that 
trauma may be associated with loss of hippocampal neurons.2 The 
hippocampus is the site of highest expression of the three members of the 
NGF family: nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF) and neurotrophin-3 (NT-3) 3, and there is data suggesting that they 
play a role in stress-mediated hippocampal atrophy. 
 
Recently we showed that exposing young (“adolescent”) animals (PND 28) to 
time-dependent sensitization (TDS), decreased glucocorticoid receptors in the 
dentate gyrus of the hippocampus and increased basal corticosterone levels 
in adulthood.4 These changes were reversed by pretreatment with the 
serotonin selective re-uptake inhibitor (SSRI), escitalopram.4 The present 
study focused on the effects of TDS during adolescence on behavior and 
neurotrophin levels in adulthood. We hypothesised that early trauma would 
lead to behavioral abnormalities in adulthood and these would be associated 
with reduced hippocampal neurotrophin levels 
 
Materials and Methods  
 
Trauma Procedure 
All procedures were approved by the Committee for Ethical Animal Research. 
Male Sprague-Dawley rats (n=19) were housed in pairs under standard 
laboratory conditions.  Based on the TDS model 5,6, the experimental group 
(n=10) was subjected to a triple stressor on PND 28 followed 7 days later (day 
35) by the first re-stress session and 25 days later (day 60 = adulthood) by the 
second re-stress session.  
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Behavioral assessment  
Behavioral assessment occurred 7 days after the last stress session when 
rats were 67 days old using the elevated plus maze (assessing time spent in 
closed and open arms, and rearing) and large open field (assessing crossing, 
and rearing) paradigms.  
 
HPA Axis Assessment 
Animals were decapitated and trunk blood collected 24 hours after behavioral 
assessment. Plasma adrenocorticotropin (ACTH) and corticosterone (CORT) 
concentrations were determined using RIA kits (IBL, Hamburg, Germany). 
Cytochrome P450 contents of microsomal preparations were determined 
following a slightly modified method of Omura and Sato.7  The microsomes 
were placed in a 1 cm cuvette and reduced by sodium dithionate. Water 
saturated with carbon monoxide (CO) was added to the suspension to convert 
cytochrome P450 to carbon monoxide-binding pigment. This conversion was 
determined spectrophotometrically. The final concentration of P450 was 
calculated from CO difference spectra of the dithionite-reduced samples. 
 
Neurotrophin levels 
Dorsal and ventral hippocampi and frontal cortex were dissected on ice. Care 
was taken not to include any white matter in the dissections. After dissection, 
samples were snap frozen in liquid nitrogen until neurotrophin analysis. Dorsal 
and ventral hippocampi and frontal cortex samples were weighed and 
suspended in 400 μl lysis buffer. The samples were sonicated (45s), vortexed 
and centrifuged at 12000 rpm for 30 min at 4 0C and the supernatants were 
collected. Concentrations of NGF, BDNF and NT-3 were determined with E-
Max ImmunoAssay system (Promega, Madison, Wisconsin, USA). 
 
Results: 
Behavior  
There were no differences in time spent in the closed vs open arms in the 
elevated plus maze, or in crossing in the open field.  However, TDS 67 
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animals showed a significant increase in rearing compared to controls in both 
paradigms (p<.01). 
 
HPA Axis 
There were no differences in ACTH between controls (20.24 ± 3.58 pg/ml) 
and TDS 67 (22.24 ±1.74 pg/ml) animals [p = .63]. There was, however, a 
significant effect in CORT (figure 1). TDS 67 animals had significantly higher 
levels of corticosterone compared to controls [p < .05].  Pooled concentrations 
of cytochrome P450 were 0.54nM/mg protein for controls and 0.11nM/mg 
protein for TDS 67 animals respectively.  
 
Neurotrophin expression 
There were no effects of TDS on NGF levels in the dorsal [p = .21], ventral 
hippocampus [p = .07] or frontal cortex [p = .18]. TDS 67 animals had 
significantly lower levels of BDNF in the dorsal hippocampus [p < .05]. There 
were no effects of TDS on BDNF levels in the ventral hippocampus [p = .06] 
or frontal cortex [p = .98]. TDS 67 animals had significantly lower levels of NT-
3 in the dorsal hippocampus [p < .05] and ventral hippocampus [p < .01]. 
There were no differences in the frontal cortex between TDS 67 animals and 
controls [p = .32]. 
 
Discussion: 
 
Animals subjected to TDS displayed some behavioral changes indicative of 
anxiety (increased rearing).  Although no alterations were observed in plasma 
levels of ACTH, basal corticosterone levels in the TDS group were 
significantly higher than the control group of animals. This is consistent with 
animal models of depression, and clinical findings in human depression. A 
decrease in adrenal cytochrome P450 concentrations was found, and may 
reflect a dysfunction or a degree of adrenal insufficiency in these rats. Thus, 
the elevated basal corticosterone levels in TDS rats may result from chronic 
HPA-axis stimulation and/or ineffective negative feedback.  
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No changes were found in NGF protein expression between traumatized 
animals and controls.  This is in contrast to previous studies where an 
increase in NGF protein expression and NGF mRNA was found in the 
hippocampus after early trauma, but these were studies of early maternal 
separation, rather than of later developmental trauma. Decrease in BDNF in 
the dorsal hippocampus, and a decrease in NT-3 in the dorsal and ventral 
hippocampus following trauma exposure during adolescence and subsequent 
adulthood re-stress, found here are consistent with basic and clinical studies 8 
suggesting a role for neurotrophins in mediating response to maternal 
separation and depression. Ventral hippocampus had higher levels than 
dorsal hippocampus, consistent with functional differences along the dorsal-
ventral axis.   
 
To our knowledge, the current study is the first to show a decrease in NT-3 
following adolescent trauma. Since NT-3 has been shown to contribute to 
neuron differentiation, synaptic plasticity and neuron survival,9 the decrease 
observed in TDS rats may hinder neurogenesis and compromise hippocampal 
neurons. A chronic decrease in hippocampal neurotrophic (NT-3) support, 
coupled with elevated levels of corticosterone, could lead to hippocampal 
neuronal loss, and increase hippocampal vulnerability to later stressors 
leading to development of behavioral abnormalities.2,10  
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Figure 1: Plasma corticosterone levels of control and traumatized 
animals.Values are expressed as mean ± SEM in ng/ml. Traumatized animals 
were subjected to a triple stressor on PND 28 (restraint stress, swim stress 
and ether inhalation), and to swim stress alone on PND 35 and PND 60. 
Trunk blood was collected PND 68. * p ≤ 0.05. 
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Abstract 
Background 
Early adverse experience is associated with later psychopathology, especially 
depression and anxiety disorders. This association may be due in part to the 
effects of stressors on hippocampal development, mediated by abnormalities 
in neurotrophin levels. The purpose of the study was to investigate the effects 
of early life trauma and adult re-stress on the levels of nerve growth factor, 
brain-derived neurotrophic factor and neurotrophin-3 in the dorsal, ventral 
hippocampus and plasma. In addition, signaling proteins of the 
phosphoinositide-3 kinase pathway were also measured.  
Young rats (n=31) were subjected to a triple stressor on post-natal day 28  
followed 7 days later by the first re-stress session and 25 days later (post-
natal day 60 = adulthood) by the second re-stress session. Brain tissue 
(dorsal and ventral hippocampi) and plasma were collected on post-natal day 
68 for neurotrophin and protein determinations.  
Results 
Compared to controls, traumatized animals had significantly lower levels of 
brain-derived neurotrophic factor in the dorsal hippocampus, and lower levels 
of neurotrophin-3 in the dorsal- and ventral hippocampus compared to 
controls. The expression levels of phosphoinositide-3 kinase (PI-3 kinase), 
protein kinase B (PKB), phosphatase and tensin homologue (PTEN), 
phospho-forkhead and phospho-AFX did not differ significantly between 
traumatized and control groups. There were also no significant differences in 
neurotrophin levels when measured in the plasma.  
Conclusions  
Our data suggest that adolescent trauma with re-stress may lead to 
decreases in neurotrophin expression in the hippocampus. Alterations in 
neurotrophin concentrations may therefore be responsible for abnormal brain 
development and function. The changes in neurotrophin levels were not 
reflected in the phosphoinositide-3 kinase pathway, suggesting a role for other 
transduction proteins to participate in its downstream effects. The dissociation 
between plasma and hippocampal neurotrophin levels cautioned against 
using parameters in the blood to indicate abnormalities in the brain. 
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Background 
 
The hippocampus is one of the few areas where production of neurons occurs 
throughout the life of animals, including humans [1]. Hippocampal 
neurogenesis can be influenced by several different environmental factors [2; 
3]. Environmental stressors, including prenatal, physical and psychosocial 
stressors [3; 4], may decrease neurogenesis and so contribute to structural 
changes in the hippocampus. Preclinical and clinical studies have suggested 
that severe stress or trauma may be associated with loss of hippocampal 
neurons [5; 6; 7]. In particular, early life trauma has been shown to be 
associated with the development of psychopathology, especially depression 
and anxiety disorders [8; 9]. Some of these disorders may be characterized by 
reduced hippocampal volume [10; 11; 12].  
 
The hippocampus is the site of highest expression of the three members of 
the neurotrophin family: nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF) and neurotrophin-3 (NT-3) [13]. Neurotrophins are essential for 
the optimal maintenance of neurons, utilizing a range of mechanisms for 
example, upregulation of the BDNF pathway enhances the survival and 
function of neurons [14], the cAMP-CREB-BDNF pathway induces expression 
of the anti-apoptotic protein bcl-2 [15], NGF promotes growth, plasticity and 
survival of neurons [16; 17; 18]. 
Consistent with this important role is evidence that neurotrophins such as 
BDNF play a role in mediating antidepressant effects [19; 20; 21]. 
Preclinically, electroconvulsive seizures increased BDNF in the hippocampus 
of rats [22], and bilateral infusion of BDNF in the hippocampus of rats exposed 
to the learned helplessness or forced swim tests paradigms had 
antidepressant effects [19]. In humans diagnosed with remitted major 
depressive disorder, there was a decreased response of serum BDNF levels 
after tryptophan depletion when compared to healthy controls [23].  
 
There are a number of inconsistencies in the literature regarding the role of 
neurotrophins in stress-related abnormalities. NGF levels were decreased in 
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animal models of depression [24], but increased in models of neonatal 
stimulation [25] and environmental enrichment [26]. Furthermore, significant 
increases in NGF levels have been shown after cold water swim stress [27] 
and NGF is suggested to activate the hypothalamic-pituitary-adrenal (HPA) 
axis. Some controversy remains regarding the role of NT-3 in stress-induced 
psychopathology [28]. It has been reported that 8 hours of immobilisation 
stress reduces NT-3 mRNA levels in the hippocampus [29], while others have 
reported an increase in NT-3 mRNA levels in the hippocampus and dentate 
gyrus following chronic but not acute immobilisation stress [30]. It is possible 
that one explanation lies in the difference between NT-3 expression after 
single vs repeated stress.                                                                                                               
 
NGF, BDNF and NT-3 bind to tropomyosin related kinase (Trk) receptors [31; 
32]. NGF binds to TrkA, BDNF to TrkB and NT-3 to TrkC and to a lesser 
extent also TrkB [32]. Trk receptors are phosphorylated at tyrosine residues 
and activate three major pathways, the Ras/MAPK cascade, inositol 
triphosphate (IP3) dependent Ca2+ release and the phosphoinositide-3 kinase 
(PI-3 kinase) [32; 33].  
In order to understand the underlying mechanism, a focus on PI-3 kinase 
would be useful. The PI-3 kinase pathway is crucial for cell survival [33; 34] 
where it links proteins such as poly(adenosine diphosphate-ribose) 
polymerase (PARP) and Forkhead proteins [35; 36]. PARP is activated during 
apoptosis when it is cleaved by apoptotic proteases such as caspase 3 and 7. 
This pathway is therefore associated with cell death [37]. On the other hand, 
phosphorylation of forkhead proteins can be mediated via neurotrophin 
signaling and thereby play a role in neurotrophin mediated cell survival [35].  
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN), is a 
phosphatase that has been shown to be a negative regulator of the PI-3 
kinase/Akt pathway and to inhibit cell survival [38]. It has the ability to remove 
phosphates from lipids and helps regulate PI-3 kinase action [39].   
 
There is a growing literature documenting the effects of early life adverse 
events. The majority of this work has focused on stressful situations around 
the immediate postnatal period [40; 41; 42], and our group has recently 
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focused on the effects of stress in adolescent animals (PND 28) plus adult re-
stress.  This work demonstrated structural and functional changes in the 
hippocampus as evidenced by a decrease in glucocorticoid receptors in the 
dentate gyrus and an increase in basal corticosterone levels in adulthood [43]. 
These changes were reversed by pre-treatment with the serotonin selective 
re-uptake inhibitor (SSRI), escitalopram [43]. Nevertheless, hippocampal 
neurotrophin levels were unchanged 24 hours after the adulthood re-stress 
[44]. Whilst decreases in BDNF mRNA only 4 hours after a corticosterone 
injection has been reported [45], it seems that a longer time period is required 
for BDNF protein levels to be affected. The aim of the present study was 
therefore to investigate whether changes in hippocampal neurotrophin levels 
and PI-3 kinase signaling proteins would occur 8 days after the last re-stress.  
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Results 
 
Neurotrophin expression in hippocampal tissue 
NGF protein levels 
On PND 68 there were no effects of TDS on NGF levels in the dorsal (p = .21) 
or ventral hippocampus (p = .07) (figure 1). 
 
BDNF protein levels 
TDS 68 animals had significantly lower levels of BDNF in the dorsal 
hippocampus compared to controls (p ≤ .05). A numerical difference in ventral 
hippocampal BDNF levels between controls and TDS 68 animals did not 
reach statistical significance (p = .06) (figure 2).  
 
NT-3 protein levels 
TDS 68 animals had significantly lower levels of NT-3 in the dorsal 
hippocampus (p ≤ .05) and ventral hippocampus (p ≤.01) compared to 
controls (figure 3) on PND 68. 
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Figure 1: Histograms depicting NGF protein concentrations in the dorsal and 
ventral hippocampus of control and traumatized animals. Values are 
expressed as mean ± SEM (n = 19) in pg/mg wet weight.  * p ≤ 0.05. 
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Figure 2: Histograms depicting BDNF protein concentrations in the dorsal and 
ventral hippocampus of control and traumatized animals. Values are 
expressed as mean ± SEM (n = 19) in pg/mg wet weight.  * p ≤ 0.05.  
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Figure 3: Histograms depicting NT-3 protein concentrations in the dorsal and 
ventral hippocampus of control and traumatized animals. Values are 
expressed as mean ± SEM (n = 19) in pg/mg wet weight.  * p ≤ 0.05, ** p≤ 
0.01. 
 85
 
Stressor control experiment 
There were no effects of either the “triple stressor day + re-stress day 35” or 
“stress day 60 only” on BDNF levels in the dorsal [F(2,34) = 0.287, p = .75], 
ventral hippocampus [F(2,34) = 0.99, p = .38] or on NT-3 levels in the dorsal 
[F(2,34) = 2.022, p = .15], ventral hippocampus [F(2,34) = 0.356, p = .70] or 
on NGF levels in the dorsal [F(2,34) = 0.186, p = .83] or ventral hippocampus 
[F(2,34) = 1.371, p = .27]. 
 
Neurotrophin expression in plasma 
BDNF and NT-3 plasma protein levels 
There were no effects of TDS on BDNF (p = .40) or NT-3 (p = .23) protein 
levels in the plasma. 
 
Western Blots 
There were no differences between control and TDS 68 animals in protein 
levels (figure 4) of PI-3 kinase in the dorsal (p = .91) or ventral hippocampus 
(p = .96), PKB/Akt in the dorsal (p = .53) or ventral hippocampus (p = .31), 
PTEN in the dorsal (p = .89) or ventral hippocampus (p = .81), or phospho-
forkhead (p = .08) and phospho-AFX (p = .32) in the ventral hippocampus. In 
addition, there were no significant differences in β-tubulin in any of the blots, 
indicating equal protein loading.  
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Figure 4: Representative Western Blot images of PI-3 kinase, PKB/Akt, PTEN, 
phospho-Forkhead and phospho-AFX in the hippocampus. In addition, β-
tubulin expression did not differ between control and traumatized animals, 
which indicates equal protein loading (n = 12).   
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Discussion 
Early adverse events have been suggested to contribute to psychopathology 
later in life [8; 9]. A number of studies have focused on identifying the 
molecular mediators of this process [46; 47]. Here we were able to show that 
early trauma plus later re-stress, but not early or late stress alone, were 
associated with a decrease in BDNF levels in the dorsal hippocampus, and a 
decrease in NT-3 in the dorsal and ventral hippocampus following trauma 
exposure during adolescence and subsequent adulthood re-stress. This is 
consistent with basic studies and indirectly with clinical studies, which provide 
evidence for the role of neurotrophins in mediating depression [18; 19; 21] and 
response to stress [29; 48]. Other animal models of early life stress, where 
rats and mice were exposed to maternal separation also show decreased 
levels in BDNF in the hippocampus [49; 50]. 
 
Furthermore, we demonstrate a differential regulation of dorsal and ventral 
hippocampal BDNF levels, with the ventral having higher levels than the 
dorsal hippocampus. Available evidence indicates that the hippocampus is 
functionally heterogeneous along the dorsal-ventral axis.  The hippocampus is 
known to have an important role in memory, as well as in emotional 
processing. The dorsal hippocampus appears to be preferentially involved in 
spatial learning, while the ventral hippocampus is crucial for anxiety-like 
behaviour [51]. For example, electrolytic lesioning of the ventral but not the 
dorsal hippocampus results in reduced freezing behavior to context, tone 
conditioned stimuli as well as decreased escape latency from enclosed arms 
of the elevated T-maze, indicating less anxious behaviour [52].  
 
In the current study we have shown a decrease in NT-3 following adolescent 
trauma. Since NT-3 has been shown to contribute to neuron differentiation 
[53], synaptic plasticity [54] and neuron survival [18], the decrease observed 
in TDS rats may hinder neurogenesis and compromise hippocampal neurons. 
Indeed, NT-3 is known to prevent neurotoxic-induced degeneration of adult 
brain noradrenergic neurons [55]. Therefore a chronic decrease in 
hippocampal neurotrophic (NT-3) support, coupled with elevated levels of 
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corticosterone, could lead to hippocampal neuronal loss [56], and increase the 
vulnerability of the organism to later stressors [7; 57].  
 
No changes were found in NGF brain protein expression between traumatized 
animals and controls.  This is in contrast to previous studies where an 
increase in NGF protein expression [58] and NGF mRNA [59] was found in 
the hippocampus after early trauma. However, these were studies of early 
maternal separation (PND 3 or PND 9 and PND 16), whereas the current 
study focused on adolescent trauma. 
 
We also measured plasma BDNF and NT-3 levels to see whether the 
changes in hippocampal neurotrophin levels were reflected in the blood. No 
changes were evident in the plasma BDNF or NT-3 levels of traumatized 
animals when compared to controls. This is in contrast to a recent clinical 
study that showed a decrease in plasma BDNF levels in patients diagnosed 
with depression [60]. It is therefore possible that a dissociation between brain 
and plasma neurotrophin levels exists in our animals, unlike human subjects.  
 
No changes were found in PI-3 kinase, PKB/Akt, PTEN, phospho-Forkhead 
and phospho-AFX in the areas examined in the hippocampus. There is the 
possibility that adolescent trauma would alter the expression of other proteins 
in the Ras/MAPK cascade or IP3 dependent Ca2+ release pathways, since 
these are also activated by Trk receptors [32] and susceptible to both 
psychosocial [61] and physical stressors [62].   
 
Conclusion 
In summary, adolescent trauma causes a decrease in hippocampal BDNF and 
NT-3 but not in total levels of certain PI-3K pathway constituents. In addition, 
the experiments done here demonstrate the value of focusing on multiple 
stressors over time.  In this study, controls that were subjected to trauma but 
not to re-stress as adults did not show changes in neurotrophin levels. Further 
studies will focus on repetitive stressors and other intracellular signaling 
proteins to advance our understanding about the interaction of these 
parameters and the associated molecular changes. 
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Methods  
 
Animals 
Male Sprague-Dawley rats (n = 68) were studied. Animals were housed in 
pairs under standard laboratory conditions (12/12 hours light/dark cycle, food 
and water ad libitum) in the central animal research facility of the University of 
Stellenbosch. All procedures were approved by the Committee for Ethical 
Animal Research. 
 
Trauma procedure 
The trauma procedure is based on the TDS model where a single exposure of 
sequential stressors of escalating severity is followed by a subsequent 
exposure to one of the stressors 7 days later [63; 64; 65]. The rationale is that 
the frequency of exposure to situational reminders contributes to the 
maintenance over time of fear-related behavioral disturbances. Young rats 
were subjected to a triple stressor on PND 28 followed 7 days later (day 35) 
by the first re-stress session and 25 days later (day 60 = adulthood) by the 
second re-stress session. The triple stressor consisted of being placed in a 
plexiglass restrainer for 2hrs with the tail-gate adjusted to keep the rat well 
contained without impairing circulation to the limbs. Immediately thereafter, 
the rats were placed individually in 18 cm of ambient water (25°C) in a 
perspex swim tank and forced to swim for 20 minutes. After gently drying the 
rat with a soft towel and 30 minutes recovery, each rat was then immediately 
exposed to ether vapors until loss of consciousness. The animals were then 
placed in their home cages for further experimentation.  
 
Experimental design 
For the both the neurotrophin and western blot experiments, animals were 
divided into two experimental groups (brain and plasma neurotrophin 
experiment total n = 19; western blot experiment total n = 12): control 68 and 
TDS 68 (8 days post second re-stress). 
In addition to the above mentioned groups, a stressor control experiment was 
done (n = 37) where animals were divided into 3 groups (group 1: control, 
group 2: triple stressor day 28 + re-stress day 35, group 3: stress day 60 only) 
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to measure neurotrophin levels. This control experiment was intended to show 
that the complete combination of stressors (ie triple stressor day 28 + re-
stress day 35 + second re-stress day 60) were needed to affect the 
neurotrophin levels.     
 
Tissue dissection and blood collection 
The dorsal and ventral hippocampi were dissected on ice. Care was taken not 
to include any white matter in the dissections. After dissection, samples were 
snap frozen in liquid nitrogen until neurotrophin analysis. For plasma 
determinations, trunk blood was collected in chilled EDTA tubes after 
decapitation. Blood was centrifuged at 4 degrees for 5min at 3000rpm and 
plasma stored in liquid nitrogen until analysis.  
 
Measurement of neurotrophin levels 
The dorsal and ventral hippocampi samples were weighed and suspended in 
400 μl lysis buffer [137mM NaCl, 20mM Tris-HCl (pH 8.0), 1% NP40, 10% 
glycerol, 1mM PMSF, 10 μg/ml aprotinin, 1 μg/ml leupeptin and 0.5mM 
sodium vanadate]. The samples were sonicated (45s), vortexed and 
centrifuged at 12000 rpm for 30 min at 4 0C and the supernatants were 
collected.  
The concentrations of NGF (tissue only), BDNF and NT-3 were determined 
using the E-Max ImmunoAssay system (Promega, Madison). Standard 96-
well flat-bottom Greiner ELISA plates were incubated with carbonate coating 
buffer containing either polyclonal anti-NGF, monoclonal anti-BDNF or 
polyclonal anti-Human NT-3 overnight at 4 0C. The next day the plates were 
blocked with 1 x block and sample buffer for 1 h at room temperature. Serial 
dilutions of known amounts of NGF, BDNF and NT-3 ranging from 500 to 0 
pg/ml (NGF and BDNF) and 300 to 0 pg/ml (for NT-3) were performed in 
duplicate for the standard curve for each set of rat tissue. For both the 
standards and samples, 100 μl was added to each well in duplicate and 
incubated for 6 h (NGF and NT-3) or 2 h (BDNF) at room temperature. 
Plasma samples (BDNF and NT-3) were assayed in triplicate. The wells were 
then incubated with a secondary monoclonal anti-NGF, secondary monoclonal 
anti-NT-3 (overnight at 4 0C) or anti-human BDNF polyclonal antibody (2 h 
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room temperature). Then the wells were incubated with anti-rat IgG (NGF), 
anti-IgY (BDNF) or anti-mouse IgG (NT-3) conjugated to HRP for 2.5 h (NGF 
and NT-3) or 1 h (BDNF) at room temperature. A TMB solution was used to 
develop color in the wells for 10 min (NGF and BDNF) or 15 min (NT-3) at 
room temperature. The reaction was stopped with the addition of 1 N HCl to 
the wells. The absorbance was read at A450 within 30 min on a Bio-Rad 
benchmark microplate reader with Microplate Manager version 5.2 software. 
Data are expressed as pg/mg wet weight for the tissue samples and pg/ml for 
the plasma samples.   
 
Western Blots 
Dorsal and ventral hippocampi of control and traumatized rats were lysed in 
buffer containing 50mM Tris-HCl (pH 7.4), 1% sodium deoxycholate, 50mM 
sodium fluoride, 20um zinc chloride, 1mM sodium vanadate, 0.5 mM PMSF, 
2ug/ml aprotinin and 2ug/ml leupeptin. After homogenizing, samples were 
centrifuged at 14000 rpm for 30 minutes at 4 deg. Protein concentration was 
determined from the cleared supernatant using a Bradford reagent kit (Bio-
Rad). Samples were aliquotted, boiled in MOPS XT sample buffer (Bio-Rad) 
at 95 deg for 5 min with XT reducing agent (Bio-Rad) and frozen in at -80 until 
analysis. 
 
Equal concentrations of protein (30-50ug) were loaded in each well and 
proteins were separated by SDS-PAGE on a Criterion XT system using pre-
cast 4-12% Bis-Tris gels (Bio-Rad). The proteins were transferred to a 
nitrocellulose membrane and blocked overnight in Detector Block solution 
(KPL) at 4°C. The following day the membranes, blotted for PI-3 kinase, were 
incubated with anti-PI-3 kinase (1:2000, Upstate) for 1 h at room temperature.  
In addition, other membranes were blocked for 1 h at room temperature in 
Detector Block solution (KPL) and incubated overnight at 4°C with anti-
Akt/PKB, anti-PTEN or anti-phospho-Forkhead (all 1:1000, Cell Signaling). 
Anti-phospho-Forkhead also recognizes anti-phospho-AFX.  After incubation 
the membranes were washed in PBS-Tween 20 (0.1%) and incubated with 
either an anti-mouse or anti-Rabbit HRP linked antibody (Amersham) for 1 h 
at room temperature. After extensive washing the protein bands were 
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visualized by chemiluminesence using LumiGlo Reserve (KPL) and put on 
ECL Hyperfilm (Amersham). After visualization the membranes were stripped 
and incubated overnight with anti-β-Tubulin (1:1000, Cell Signaling) to 
determine equal protein loading.   
 
Statistical analysis 
Data were analyzed with either an independent Students t-test or ANOVA 
(stressor control experiment) with SPSS version 11.0 software. Protein bands 
were imaged using a densitometer and total number of pixels counted using 
UN-SCAN-IT gel version 5.1 (Silk Scientific, USA). Differences were 
considered significant if p ≤ .05.  
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Abstract 
 
Despite advances in the treatment of anxiety disorders, there is a need for 
medications with greater efficacy and fewer side-effects. Advances in 
techniques to facilitate high throughput, mass analysis of proteins potentially 
allows for new drug targets, with a shift in focus from membrane receptor 
proteins and enzymes of neurotransmitter metabolism to molecules in 
intracellular signal transduction and other pathways. A computerized literature 
search was done to collect studies on recently developed proteomic 
techniques and their application in psychiatric research. Particular techniques 
such as 2-dimensional electrophoresis (2D-SDS PAGE), 2-dimensional 
differential gel electrophoresis (2D-DiGE), isotope-coded affinity tags (ICAT) 
and isotope tags for relative and absolute quantification (iTRAQ) are 
reviewed. In addition, combination of these techniques with MALDI-TOF/TOF 
and ESI-Q-TOF mass spectrometry analysis is discussed in relation to 
possible novel signaling pathways relevant to anxiety disorders, and to the 
development of bio-markers for the evaluation of these conditions.  
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Introduction 
 
Anxiety disorders are the most prevalent of the psychiatric disorders, and are 
associated with significant disability and social costs [1]. Fortunately there 
have been significant advances in the treatment of many of these conditions, 
including generalized anxiety disorder, panic disorder, posttraumatic stress 
disorder, and social anxiety disorder [2].  Nevertheless, many patients either 
do not respond to pharmacotherapy, or suffer significant adverse events, and 
there is therefore a need for new medications.   
 
The development of medications for anxiety disorders has been a 
serendipitous process.  Early anxiolytic agents were subsequently found to act 
on a limited number of amino acid and monoamine receptors.  More recently, 
advances in cellular biology have led to a shift in focus from such receptors to 
intracellular signaling pathways [3; 4; 5]. There is growing data demonstrating 
that agents commonly used in the treatment of anxiety disorders alter mRNA 
expression of a range of signaling pathways [6].   
 
With advances in our knowledge of the human genome, there are a range of 
potential targets for the development of new agents for the treatment of 
anxiety disorders.  Nevertheless, each gene may lead to multiple protein 
targets.  Furthermore genomics has been accompanied by advances in 
proteomics.  In the current review we focus on this field, reviewing recent 
methodologies, and considering their application to the field of anxiety 
disorders. 
 
What is proteomics? 
 
One of the surprising findings of the human genome project was the relatively 
low number of human genes [7]. An explanation for the complexity of human 
biology lies in exploring the multiple products that emerge from the genome; 
the so-called transcriptome, or the entire complement of mRNA transcripts 
transcribed. Furthermore, there is subsequent modification of proteins; with 
post-translational phosphorylation, glycosylation, acetylation, nitrosation, poly-
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ADP- ribosylation, ubiquination, farnesylation, sulfation, linkage to 
glycophosphatidylinositol anchors, and SUMOylation. The 300 or more such 
modifications reported to date affect protein stability, localization, binding 
interactions and function [8].  
 
Proteomics encompasses the study of the entire protein population on a large 
scale to obtain a global view protein networks and their function in cellular 
processes and pathology [9; 10; 11]. The power of this approach has been 
illustrated in the identification of members of signal transduction pathways, of 
their post-translational modifications [12], and of their interactions in complex 
and network formation [13] over time [14]. 
 
Central to the methodology of obtaining proteomic data is the use of mass 
spectrometry [15]. Isolated proteins are digested enzymatically to yield a 
variety of peptide fragments. These are then further separated and subjected 
to high-sensitivity mass spectrometry (MS). This is followed by the 
identification of the proteins through matching the MS spectra to a large-scale 
peptide/protein database, such as Swiss-Prot or from the National Center for 
Biotechnology Information (NCBI). Advances in MS technology have made it 
possible to identify proteins in complex mixtures accurately and rapidly [16].  
 
Current proteomic strategies 
 
2D Gel Electrophoresis and 2D-DiGE 
Two-dimensional gel electrophoresis (2D-SDS PAGE) coupled to mass 
spectrometry has been widely employed in the study of proteins in biological 
samples [17]. In this method, proteins are separated in the first dimension on 
pH followed by separation on molecular weight in the second dimension (see 
figure 1). Subsequently the spots that are differentially expressed (for example 
between control and patient) are excised from the gel and trypsinated (in-gel 
digestion), yielding peptides. These peptides are subjected to MS and 
followed by matching the MS spectra to a peptide/protein database.  
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Figure 1: In two-dimensional gel electrophoresis, proteins are separated in the 
first dimension on pH, followed by separation on molecular weight (MW) in the 
second dimension. Here, proteins are separated on pH 5 to 8 in the first 
dimension. The marker on the left shows a molecular weight range from 200 
kDa to 20 kDa for the second dimension separation. 
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A variant of 2D-SDS PAGE is 2-Dimensional Differential Gel Electrophoresis 
(2D-DiGE). In this method samples from two different conditions are each 
labeled with a fluorophore, Cy3 and Cy5. The samples are then combined and 
run on one gel instead of two gels, which minimizes gel-to-gel variation [18; 
19]. Scanning of the gels at different wavelengths then allows for the images 
to be overlaid. In addition, the use of fluorescent dyes to label proteins, 
increases sensitivity and thereby enhancing identification of proteins which 
are expressed at very low levels in the cell. A third dye (Cy2) can be used as 
an internal standard by pooling an equal amount of all the samples. Every 
spot would therefore be represented in the standard, increasing quantification 
and the power of statistical analysis between gels.  
It has been shown that up to 1000 protein spots can be adequately resolved 
[20] and post-translational modifications can be detected on 2D gels [21]. 
Despite the advantages of 2D-DIGE over 2D-SDS PAGE, there are still some 
disadvantages. The expression of cytosolic proteins is favoured by 2D 
electrophoresis above membrane proteins [22; 23] and the problem of gel-to-
gel variation is not totally eliminated. To circumvent some of these problems, 
attention has been given to keeping proteins in-solution.  
 
Isotope-coded affinity tags (ICAT) 
One such relative quantification method where proteins are kept in-solution is 
by tagging the proteins with stable isotopes, also known as isotope-coded 
affinity tags (ICAT). In short, samples from a control and experimental 
condition are each tagged with stable isotope, combined, digested and 
subjected to MS analysis. The newest ICAT reagent has a thiol-specific 
reactive group adjacent to an alkyl linker, which contains either nine [12C] or 
nine [13C] atoms, resulting in a mass difference of 9 daltons between the 
control and experimental/patient sample [24]. By labeling each sample with its 
own isotope, the relative ratio of the peptides of both conditions can be 
compared in the same MS run. An added advantage of ICAT labeling is the 
fact that the reagent labels only cysteine containing peptides, thereby 
decreasing sample complexity. The ratios between control and 
experimental/patient peptides are calculated by commercially available 
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software such as ProICAT (Applied Biosystems).   
 
Isotope tags for relative and absolute quantification (iTRAQ) 
Recently another relative and absolute (when using internal standards) 
quantification method for labeling proteins in solution has been developed, 
called iTRAQ [25] (Applied Biosystems Inc, CA). Instead of labeling cysteine 
containing peptides, labeling is done on primary amines, which allows tagging 
of most tryptic peptides. In addition, whereas ICAT labels only two different 
conditions, iTRAQ allows up to four different conditions, making it ideal for 
pharmacology experiments (control + no treatment, control + treatment, 
experimental + no treatment, experimental + treatment). The quantification of 
the tags is performed in MS/MS (see next section), where the relative 
abundance of the four product ions (114, 115, 116, 117) is measured after 
cleavage from the tags. Here too the ratios are calculated by commercially 
available software such as ProQuant (Applied Biosystems Inc, CA) or 
freeware such as i-Tracker [26].  
 
Mass Spectrometry and databases in proteomic analysis 
 
Advances in mass spectrometry have made it possible to not only determine 
peptide masses but also peptide sequences – allowing greater accuracy in 
identification of proteins. After digesting proteins with an enzyme, such as 
trypsin, the resulting peptides can either be spotted on a plate for matrix-
assisted laser desorption/ionization time-of-flight (MALDI-TOF) analysis or be 
injected into the mass spectrometer via high-performance liquid 
chromatography (HPLC) when using electrospray ionization quadrupole time-
of-flight (ESI-Q-TOF) mass spectrometry. The peptides are ionized by either 
laser or applying an electrical charge when emerging from the HPLC column. 
In the TOF module, the time is measured that it takes for ions to travel through 
the flight tube. Where MALDI-TOF mass spectrometry uses the weight of 
peptides [27; 28], also termed a peptide mass fingerprint (PMF), ESI-Q-TOF 
mass spectrometry uses peptide sequences to determine identification [29; 
30]. Recently, development of MALDI-TOF-TOF mass spectrometry, allows 
peptides [31; 32] as well as intact proteins [33], to be sequenced using MALDI 
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technology. As noted earlier, the data (PMF or peptide sequences) generated 
from the mass spectrometer are then matched against a protein database to 
identify possible peptide-protein matches through the use of different 
algorithms such as Mascot [30] or Sequest [34].   
 
Application of proteomic strategies in animal models of psychiatric disorders 
 
A number of these proteomic techniques have been applied to study the 
nervous system in general (neuroproteomics) and to animal models of stress 
in particular [35]. Combining 2D-SDS PAGE and MALDI-TOF mass 
spectrometry, the researchers identified 21 hippocampal proteins, from 
different subcellular locations in an animal model of repeated psychosocial 
stress. These included proteins involved in intracellular signaling, synaptic 
plasticity, cytoskeleton regulation and energy metabolism. In addition, the 
protein changes observed were different from a single exposure as opposed 
to multiple exposures [35]. Some of these data are consistent with those 
found in previous studies, for example the increase in HSC71 is also evident 
in restraint-water immersion stress [36]. Proteomic analysis of hippocampal 
proteins in this model of repeated psychosocial stress using more sensitive 
2D-DiGE or iTRAQ tagging may provide additional data on differentially 
expressed proteins.    
 
The hyperanxious (HAB-M) and hypoanxious (LAB-M) CD1 mouse lines have 
been proposed as a model of anxiety. Proteomic analysis of selected brain 
areas in these animals (hypothalamus, amygdala, and motor cortex), using 2D 
SDS PAGE, found that the enzyme glyoxalase-I (Glx1) was 5 times higher in 
LAB-M animals compared with HAB-M animals [37]. This is reminiscent of 
data from an animal model for Alzheimer disease, where the Glx1 gene was 
upregulated [38]. In addition, a link has been found between the Glx1 gene 
and depression [39]. Future directions could include the validation of this 
protein in other animal models of anxiety disorders [40].   
 
In another animal experiment using 2D-SDS PAGE, chronic administration of 
either venlafaxine or fluoxetine to adult rats was shown to differentially 
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regulate at least 33 cytosolic proteins in the hippocampus [41]. Mass 
spectrometry analysis identified proteins that included, but were not limited to, 
those associated with neurogenesis (eg. insulin-like growth factor and glia 
maturation factor) and synaptic plasticity (eg. Ras-related protein 4a, Ras-
related protein 1b, heat shock protein 10).  This is consistent with previous 
studies where fluoxetine prevented the increase in heat shock protein after 
phencyclidine (PCP) and dizocilpine (MK801) induced neurotoxicity [42].  It 
would be interesting to see if similar results would be obtained using the 4 
isobaric tags of iTRAQ in a stress experiment with and without 
pharmacological treatment.  
 
These initial studies demonstrate the promise of applying proteomic 
techniques to validated animal models of anxiety. Whether the differentially 
expressed proteins are also applicable as a biomarker in a clinical setting 
remains to be seen. The use of more sensitive techniques, such as 2D-DiGE 
and iTRAQ tagging combined with highly sensitive tandem mass spectrometry 
(MALDI-TOF-TOF and ESI-Q-TOF) may lead to the discovery of additional 
proteins. In addition, the analysis of the phosphoproteome of this animal 
model may provide insight into post-translational modifications of proteins.     
 
Application of proteomic strategies in the clinical setting 
 
The use of neuroproteomics (or neuromics) to investigate protein expression 
and changes related to psychiatric disorders is at an early stage [43]. Initial 
work has begun in schizophrenia, Alzheimer's disease, and Parkinson's 
disease [reviewed in 43]. In postmortem frontal cortical tissue, patients with 
either schizophrenia, bipolar disorder or major depressive disorder, showed 
changes in proteins associated with synaptic plasticity (glial fibrillary acidic 
protein)  and enzymatic proteins (fructose biphosphate aldolase) seen with 2D 
SDS PAGE and mass spectrometry [44].  
 
Cerebral spinal fluid (CSF) proteomic analysis of patients diagnosed with 
either chronic fatigue syndrome (CFS), Persian Gulf War Illness (PGI), or 
fibromyalgia showed that CFS and PGI shared 20 proteins not detectable in 
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the control sample [45]. These included alpha-1-macroglobulin, and amyloid 
precursor-like protein 1. In addition, 62 of 115 proteins were newly described 
in terms of a possible role in psychiatric disorder. Future steps would be 
investigating and validating these proteins in animal models. In addition, using 
techniques like prefractionation of the cerobral spinal fluid may increase the 
identification of additional proteins. Also, using an in-solution tagging 
approach such as ICAT or iTRAQ may aid in identifying proteins which are 
differenitally expressed between patients.      
 
In a genetic microarray study, differential gene expression signatures were 
identified in leucocytes of traumatized patients who were subsequently 
diagnosed with posttraumatic stress disorder (PTSD) compared to those who 
remained well [46]. This approach shows the potential of mass analysis 
techniques in the context of anxiety disorders. A similar protein approach, 
using 2D-DiGE or iTRAQ, could potentially be used to study the differential 
CSF proteome expression in patients diagnosed with an anxiety disorder vs 
healthy controls.      
 
Conclusion  
 
There have been significant developments in proteomics in general, and there 
is potential to extend this work to the study of basic models of anxiety, as well 
as to clinical populations.  A detailed understanding of the psychobiology of 
psychiatric disorders will ultimately require a comprehensive understanding of 
the relevant proteins that underpin symptoms.  Current methods are available 
for exploring the neuroproteome. For instance, analysis of the mouse 
hippocampal membrane proteome has revealed more than 1,685 proteins 
using a highly sensitive Fourier transform mass spectrometer [47].  In 
addition, the initial pilot studies of the Human Proteome Organisation (HUPO) 
Brain Proteome Project (BPP) of human and mouse brain samples, is in an 
advanced stage [48]. This promises further elucidation of neural proteins and 
their possible functions.  
 
 114
Further development of advanced protein technologies is still needed. 
Comparison between a Q-TOF and a highly sensitive Fourier transform mass 
spectrometer in the analysis of the mouse hippocampal membrane proteome 
revealed 862 proteins (Q-TOF) vs 1685 (Fourier transform) [47]. This 
illustrates how more sensitive technologies could aid in the identification of a 
greater number of proteins. Currently the databases used for peptide/protein 
searches do not contain all species. In addition, very large data files are 
generated by high-throughput proteomic experiments, causing a “bottle-neck” 
during analysis, since often peptide sequences have to be manually inspected 
to avoid false positives.  
 
There is a growing evidence-base, however, which suggests that differential 
analysis of expressed proteins can aid in the discovery of biomarkers and of 
novel therapeutic targets.  Ultimately this may lead to the development of 
more specific pharmacological agents for the treatment of psychiatric 
disorders, including the anxiety disorders.   
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Abstract 
 
Early life trauma is associated with psychopathology in adulthood. These 
pathologies include depression and anxiety disorders. This association may 
be due in part to the effects of trauma on hippocampal development and 
protein expression. The purpose of the study was to investigate the effects of 
early life trauma and adult re-stress on ventral hippocampal protein 
expression using commercially available protein arrays and 2D-SDS PAGE 
combined with liquid chromatography tandem mass spectrometry (LC-
MS/MS).  
Adolescent rats (n=19) were subjected to a triple stressor on post-natal day 
28  followed 7 days later by the first re-stress session and 25 days later (post-
natal day 60 = adulthood) by the second re-stress session. Ventral 
hippocampi were collected on post-natal day 68 for protein expression 
determinations.  
Compared to controls, traumatized animals showed an increase in Ca2+ 
homeostatic proteins, dysregulated signaling pathways and energy 
metabolism enzymes, cytoskeletal protein changes, a decrease in 
neuroplasticity regulators, energy metabolism enzymes and an increase in 
apoptotic initiator proteins. These include, but were not limited to, S-100B, 
phospho-JNK, ARNO, Caspase 9, 10 and 12, MAP-1b, syntaxin and DRP-2. 
A total number of 40 proteins were differentially regulated by adolescent 
trauma. 
These results indicate the extensive impact of adolescent trauma on adult 
brain development and may point to novel targets for pharmacological 
treatment.  
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Introduction 
 
Early life trauma is known to cause behavioural abnormalities later in life 
(Heim and Nemeroff, 2001; Kendler et al., 1992). These include mood and 
anxiety disorders such as depression and posttraumtic stress disorder 
(PTSD). An important brain area implicated in the pathology of these 
disorders is the hippocampus (Duman et al., 1997; Duman et al., 1999; 
McEwen, 1999). For example, a reduced hippocampal volume has been 
documented in patients diagnosed with depression (Neumeister et al., 2005) 
and PTSD (Kitayama et al., 2005). Support for the involvement of an 
abnormal hippocampus in these disorders comes from basic studies where 
animals, subjected to different stressors (physical, psychosocial, and prenatal 
stressors) show decreased hippocampal neurogenesis, which may contribute 
to the observed structural changes in the hippocampus (Czeh et al., 2002; 
Lemaire et al., 2000). However the underlying molecular mechanisms 
responsible for mediating the effects of early life trauma, remains unclear.  
 
We have recently shown that animals which were subjected to adolescent 
trauma and adulthood re-stress have higher basal corticosterone levels and 
decreased glucocorticoid receptors in the dentate gyrus of the hippocampus 
(Uys et al., 2006b). In addition, traumatized animals also showed a decrease 
in BDNF in the dorsal hippocampus and a decrease in NT-3 in the dorsal and 
ventral hippocampus. This trauma-induced decrease in neurotrophins was 
accompanied by behavioural hyperarousal (Uys et al., 2006a) but not by 
changes in the proteins, phosphoinositide-3 kinase (PI-3 kinase), protein 
kinase B (PKB), phosphatase and tensin homologue (PTEN), phospho-
forkhead and phospho-AFX (Uys et al., submitted). However, numerous other 
cell signaling and cell proliferation pathways may participate in regulating 
trauma-induced changes. For instance, the Ras/MAPK cascade or inositol 
triphosphate (IP3) dependent Ca2+ release pathways are activated by physical 
stressors (Herbert et al., 2005) or psychosocial stress (Pardon et al., 2005).  
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In order to investigate changes in protein expression after early life trauma on 
a global scale we employed a systems biology approach by using proteomic 
methods – protein arrays and 2D-SDS PAGE combined with liquid 
chromatography tandem mass spectrometry (LC-MS/MS). Here we were able 
to show that animals subjected to early life trauma show signs of cellular 
stress, cell cycle arrest, initiation of apoptotic mechanisms and cell signaling 
dysregulation.     
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Methods 
 
Animals 
 
Male Sprague-Dawley rats (N = 19) were studied. Animals were housed in 
pairs under standard laboratory conditions (12/12 hours light/dark cycle, food 
and water ad libitum) in the AALAC acredited central animal research facility 
of the University of Stellenbosch. All procedures were approved by the 
Committee for Ethical Animal Research. 
 
Trauma procedure 
The trauma procedure is based on the TDS model where a single exposure of 
sequential stressors of escalating severity is followed by a subsequent 
exposure to one of the stressors 7 days later (Liberzon et al., 1997; Yehuda 
and Antelman, 1993; Harvey et al., 2003). The rationale is that the frequency 
of exposure to situational reminders contributes to the maintenance over time 
of fear-related behavioral disturbances. Young rats were subjected to a triple 
stressor on post-natal day (PND) 28 followed 7 days later (PND day 35) by 
the first re-stress session and 25 days later (PND day 60 = adulthood) by the 
second re-stress session. The triple stressor consisted of being placed in a 
plexiglass restrainer for 2hrs with the tail-gate adjusted to keep the rat well 
contained without impairing circulation to the limbs. Immediately thereafter, 
the rats were placed individually in 18 cm of ambient water (25°C) in a 
perspex swim tank and forced to swim for 20 minutes. After gently drying the 
rat with a soft towel and 30 minutes recovery, each rat was exposed to ether 
vapors until loss of consciousness. The animals were then placed in their 
home cages for further experimentation. Re-stress sessions consisted of 20 
minutes forced swim.   
 
Experimental design 
Animals were divided into two experimental groups: control 68 and TDS 68 (8 
days post second re-stress). On PND 68 animals were decapitated and the 
ventral hippocampi were dissected on ice. Care was taken not to include any 
 127
white matter in the dissections. After dissection, samples were snap frozen in 
liquid nitrogen until analysis.   
 
Protein array 
A commercially available antibody-based protein array (Panorama Cell 
Signaling Array, Sigma, USA) was used to determine relative differential 
expression of proteins between control 68 and TDS 68 animals. The array 
contained 224 different antibodies spotted in duplicate on nitrocellulose glass 
slides. The antibodies occured in 32 sub-arrays each containing duplicate 
spots of 7 antibodies, as well as a single positive (BSA labeled with Cy3 and 
Cy5) and negative control spot. Each sample is labeled with a different Cy dye 
(Cy3 or Cy5), combined and applied simultaneously on the array.  
 
Sample preparation for protein array 
 
Samples were prepared as recommended by the array manufacturer. In short, 
ventral hippocampi were homogenized on ice in extraction buffer with 
protease inhibitors, phosphatase inhibitors and benzonase. Protein extracts 
were clarified by centrifugation (10 000 rpm for 20 seconds) and the protein 
concentration of the supernatant was measured by the Bradford method. The 
samples were diluted to 1mg/ml and 1ml of the supernatant was used for 
labeling with Cy3 or Cy5 dyes (Amersham Biosciences). Excess dye was 
removed using Sigma Spin columns and the protein concentration of the 
eluate was measured by the Bradford method. The Cy3 and Cy5 
concentration were measured by reading the absorbance of Cy3 at 552nM, 
dividing the value by 0.15 and Cy5 at 650nM and dividing the vaule by 0.25. 
The dye to protein molar ratio was calculated to ensure a ratio > 2. Control 68 
and TDS 68 samples were mixed in equal protein concentrations (4ug protein 
each) and incubated on the array for 45 minutes at room temperature. In 
addition, each control 68 and TDS 68 sample were labeled with both Cy3 and 
Cy5 and mixed with the counterpart labeled with the other dye. This ensured 
the experiment is fully controlled and doubly tested. After extensive washing in 
phosphate buffered saline (PBS)-Tween 20 (0.1%), slides were air dried and 
prepared for scanning.       
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Protein array data analysis and normalization 
Protein array slides were scanned with a GenePix 4000A scanner (Molecular 
Devices, USA) and images were captured with GenePix Pro version 6 with 
scan resolution at 10μm. After background subtraction, values were 
normalized to a log base 2 value, where a log value (M-value) of 1 equaled a 
2-fold increase and log value of -1 a 2-fold decrease, relative to control. A 
global LOESS (also known as LOWESS) normalization (Smyth and Speed, 
2003) was used to perform a location and scale normalization of the arrays 
(R, Bioconductor software). This was necessary, since the two Cy dyes differ 
in fluorescence intensity and labeling efficiency, thereby correcting for 
intensity dependent dye-bias. A small number of housekeeping proteins were 
included on the array. It was decided not to fit the normalization curve to the 
housekeeping proteins as there are very few of them and they displayed 
considerable variation. Furthermore, they also do not cover the entire intensity 
range of the arrays. The underlying assumption we made by using the global 
LOESS approach is that the majority of proteins will not show differential 
expression with respect to the control (see figure 1). We feel that this is a 
reasonable assumption for our arrays. An exploratory analysis of the data 
confirmed this. S100 beta, which was upregulated on the protein array, was 
selected for further confirmation by Western Blot. In addition, Bcl-2 expression 
was also determined by Western Blot.  
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Figure 1: A global LOESS normalization was used to perform a location and 
scale normalization of the arrays. The majority of proteins did not show 
differential expression with respect to the control. Array 1 and Array 2 
represents the Cy3 and Cy5 dye-swap between control 68 and TDS 68. 
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Western Blot 
Ventral hippocampi of control 68 and TDS 68 rats were lysed in buffer 
containing 50mM Tris-HCl (pH 7.4), 1% sodium deoxycholate, 0.5 % NP-40, 
50mM sodium fluoride, 20μM zinc chloride, 1mM sodium vanadate, 0.5 mM 
PMSF, 2μg/ml aprotinin and 2μg/ml leupeptin. After homogenizing, samples 
were centrifuged at 14000 rpm for 30 min at 4°C. Protein concentration was 
determined from the cleared supernatant using a Bradford reagent kit (Bio-
Rad). Samples were aliquotted, boiled in MOPS XT sample buffer (Bio-Rad) 
at 95 °C for 5 min with XT reducing agent (Bio-Rad) and frozen at -80 °C until 
analysis. 
 
Equal concentrations of protein (20μg) were loaded in each well and proteins 
were separated by SDS-PAGE on a Criterion XT system using pre-cast 4-
12% Bis-Tris gels (Bio-Rad). The proteins were transferred to a PVDF 
membrane and blocked overnight in 5% Milk/PBS-Tween 20 (0.1%) at 4°C. 
The following day the membranes were incubated with either anti-S100 beta 
(1:1000, Abcam, United Kingdom) or anti-Bcl-2 (1:1000, Stressgen, USA) for 
1 h at room temperature. After incubation the membranes were washed in 
PBS-Tween 20 (0.1%) and incubated with either an anti-mouse or anti-Rabbit 
HRP linked antibody (Amersham) for 1 h at room temperature. After extensive 
washing the protein bands were visualized by chemiluminesence using 
LumiGlo Reserve (KPL) and put on ECL Hyperfilm (Amersham). After 
visualization the membranes were stripped and incubated overnight with anti-
β-Tubulin (1:1000, Cell Signaling) to determine equal protein loading.   
 
Western Blot data analysis  
Protein bands were imaged using a GS-800 calibrated densitometer (Bio-Rad, 
Hercules, CA, USA) and total optical density of pixels counted using Quantity 
1 software, version 4.5.2 (Bio-Rad, Hercules, CA, USA). Data were 
normalized for β-Tubulin levels, expressed relative to controls and analyzed 
with an independent Students t-test with SPSS version 11.0 software. 
Differences were considered significant if p ≤ .05.  
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Sample preparation for 2D electrophoresis 
Ventral hippocampi were fractionated into cytosolic fractions using a 
commercially avaliable kit (ProteoExtract Subcellular Proteome Extraction kit, 
Calbiochem). Lipids, salts and detergents were removed from the cytosolic 
proteins by precipitation using the ReadyPrep 2D clean-up kit (Bio-Rad, 
Hercules, CA, USA). Precipitated samples were re-suspended in 2D 
sample/Rehydration buffer (Bio-Rad, Hercules, CA, USA) and protein 
concentrations were measured using the RC/DC protein assay (Bio-Rad, 
Hercules, CA, USA).  
 
2D electrophoresis 
Isoelectric focusing was carried out on a 11cm immobilised pH strip (5-8, Bio-
Rad, Hercules, CA, USA). Strips were rehydrated for 12 hours with 200ug 
protein in 200ul of 2D sample/Rehydration buffer (Bio-Rad, Hercules, CA, 
USA). Focusing was carried out at 20 °C for 40 000 Vh with a maximum of 
8000 V in a Protean IEF Cell (Bio-Rad, Hercules, CA, USA). Strips, from the 
same batch, were then incubated for 15 min with gentle shaking in 
equilibration buffer I (6 M Urea, 2% w/v SDS, 2% DTT, 20% glycerol, 375 mM 
Tris pH 8.8, Bio-Rad, Hercules, CA, USA) followed by 15 min incubation in 
equilibration buffer II (6 M Urea, 2% w/v SDS, 2.5% w/v iodoacetamide, 20% 
glycerol, 375 mM Tris pH 8.8, Bio-Rad, Hercules, CA, USA). Control 68 and 
TDS 68 strips were run in triplicate on pre-cast 4-12% Criterion XT Bis-Tris 
gels, from the same batch, in Criterion XT electrophoresis cells (Bio-Rad, 
Hercules, CA, USA) for 42 minutes. Gels were fixed in 7% v/v glacial acetic 
acid and 40% v/v methanol for 1 hour followed by 2 hour staining in 
Coomassie Colloidal Blue (Sigma, USA). Gels were destained overnight in 25 
% v/v methanol. 
 
Data Analysis for 2D electrophoresis 
Images were captured on a GS-800 calibrated densitometer (Bio-Rad, 
Hercules, CA, USA) and were analyzed with PDQuest 8 Advanced software 
(Bio-Rad, Hercules, CA, USA). A number of spots that were significantly (p ≤ 
.05) differentially expressed between control 68 and TDS 68 as assesed by 
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PDQuest with a T-test, were selected for spot excision and protein 
identification by LC-MS/MS analysis. 
 
Protein Identification using LC-MS/MS         
Excised gel spots were destained, reduced, alkylated, digested with trypsin 
and the resulting peptides extracted using the Micromass MassPrep Station 
(Waters Technologies, Manchester, U.K.) running the standard digestion 
protocol supplied by the manufacturer.  The tryptic peptides were transferred 
to a cooled second 96-well microtitre plate and if necessary, stored at –20oC. 
The 96-well microtitre plate containing the extracted tryptic peptides was 
transferred to a Micromass modular CapLC and autosampler system (Waters 
Technologies, Manchester, U.K.).  A 6.4 μl aliquot of extract was mixed with 
13.6 μl of 0.1% formic acid and loaded onto a 0.5 cm LC Packings C18 5 μm 
100Å 300 μm i.d μ-precolumn cartridge (Dionex Corporation, Sunnyvale, CA, 
U.S.A).  Flushing the column with solution A (95% water, 4.9% acetonitrile, 
0.1% formic acid) desalted the bound peptides before a linear gradient of 
solution B (4.9% water, 95% acetonitrile,0.1% formic acid) at a flow rate of 
200 nlmin-1 eluted the peptides for further resolution on a 15 cm LC Packings 
C18 5 μm 5Å 75 μm i.d. PepMap analytical column (Dionex Corporation, 
Sunnyvale, CA, U.S.A). Gradient separations were 0.10 min (95%A:5%B), 3 
min (95%A:5%B), 31 min (55%A:45%B), 35min (20%A:80%B), 37min (20%A: 
80%B), 38 min (95%A:5%B), 47 min (95%A:5%B).  
The eluted peptides were analysed on a Micromass QTof Global Ultima mass 
spectrometer (Waters Technologies, Manchester, U.K.) fitted with a nano-LC 
sprayer with an applied capillary voltage of 3.5 kV.  The instrument was 
calibrated against a collisionally induced decomposition (CID) spectrum of the 
doubly charged precursor ion of GFP.  A calibration was accepted when the 
error obtained on all subsequent acquisitions was <50 ppm.  Sensitivity is 
assessed by the detection of a 500 fmol injection of GFP, with a base peak 
signal:noise ratio of >20:1 on the doubly charged ion.  Both the sensitivity and 
calibration were checked at regular intervals during the analysis.   
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The instrument was operated in data dependent acquisition (DDA) mode over 
the mass/charge (m/z) range of 50-2000.  During the DDA analysis, both MS 
and tandem mass spectrometry (CID) was performed on the most intense 
peptides as they eluted from the column.  The uninterpreted MS/MS data was 
processed using the Micromass ProteinLynx software package, which 
converted the raw data into .pkl files for use with the Mascot search engine 
(www.matrixscience.com). The data files were submitted online and the 
MS/MS files were searched against the Swiss-Prot database with Mammalia 
as subspecies.  Search parameters specified were: carbamidomethylated at 
cysteine residues, oxidized at methionine residues, one missed trypsin 
cleavage allowed, a 0.2 Da tolerance against the database-generated 
theoretical peptide and product ion masses and a minimum of 1 matched 
peptide.  If there was only 1 matched peptide, the sequence was manually 
inspected to determine a minimum of 4 consecutive Y-ions matched and a 
unique match against the theoretical protein. All protein identifications were 
significant according to the probability-based MOWSE scores (Mascot scores 
in table 2), which were reported as -10*Log10(p), where p is the probability that 
the observed match is a random event. All proteins identified were in the 
expected size based on the position in the gel.  
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Results 
 
Protein array: 
A cut-off limit of 50% up- or down-regulated was applied to the array proteins 
and 25 were found to be differentially expressed between control 68 and TDS 
68 animals using this criterium. The proteins were grouped into functional 
groups (see Table 1). 
MAP-1b, Cytokeratin, S-100b, Histone 3 (acetylated on lysine 9), phospho-
JNK, phospho-serine-FAK, syntaxin, p34 (cdc2), chk1, calcineurin, desmin, 
caspase 9, caspase 10, caspase 12, c-Myc and p57Kip2 were increased in 
TDS 68 animals.  
In contrast, cdc25C, cdk7, cdk6, ARNO, p16INK4a, c-Abl, β-tubulin 
polyglutamylated, neurofilament (200 kDa heavy chain) and phospho-Pyk2, 
showed decreases compared to controls. 
  
Western Blot analysis: 
In order to verify the protein array data, western blot analysis was performed 
on two randomly selected proteins. They were S-100B that showed increased 
expression in traumatized animals and Bcl-2 whose concentration was not 
affected by the trauma. These protein array observations were therefore 
confirmed (see figure 2).   
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Table 1: Up- or down regulated proteins on the array. A cut-off limit of 50% 
increase or decrease compared to controls was applied. Results are 
expressed relative to control. 
 
Protein M-value Fold increase 
or decrease 
Functional 
Group 
S-100B          1.37         2.58 Ca2+ homeostasis/ signaling 
Pyk2-pTyr881        -0.64 - 1.56 Ca2+ homeostasis/ signaling 
JNK activated di-
phosphopeptide 
         1.12         2.17 Ca2+ homeostasis/ signaling 
Calcineurin          0.88   1.84 Ca2+ homeostasis/ signaling 
ARNO        -1.08 - 2.11 neuroplasticity 
c-Abl        -1.02 - 1.95 neuroplasticity 
FAK-pSer910          1.11   2.16 apoptosis 
Caspase 10          0.83   1.78 apoptosis 
Caspase 9          0.82   1.77 apoptosis 
Caspase 12          0.65   1.57 apoptosis 
β-Tubulin polyglutamylated        -0.77 - 1.71 cytoskeletal 
Desmin          0.84   1.79 cytoskeleton 
Cytokeratin  1.64 3.12 cytoskeleton 
Neurofilament 200        -0.67 - 1.59 cytoskeleton 
Syntaxin          0.96   1.93 vesicular docking and fusion 
MAP-1b          1.90         3.73 Structural membrane  
Cdc25C       - 1.44       - 2.71 cell cycle 
chk1          0.94   1.91 cell cycle 
cdk7        -1.34       - 2.53 cell cycle 
cdk6        -1.22       - 2.33 cell cycle 
p16INK4a        -1.07 - 2.03 cell cycle 
p57(Kip2)          0.59   1.51 cell cycle 
p34 (cdc2)          0.95   1.92 cell cycle 
c-Myc (mono)          0.67   1.59 nuclear 
Acetyl Histone 3-Ac-Lys 9          1.37         2.58 nuclear 
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Figure 2: Histograms depicting Bcl-2 and S100 beta protein expression in the 
ventral hippocampus of animals subjected to early life trauma. Densitometric 
data were normalized for β-Tubulin levels and expressed relative to controls 
(n = 11, * p ≤ .05). Representative images of the respective blots are shown 
above.   
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2D-SDS PAGE with LC-MS/MS: 
Numerous proteins were found to be significantly differentially expressed 
between control 68 and TDS 68 animals. Proteins that were upregulated in 
traumatized animals were synaphin-1, ubiquitin carboxyl-terminal hydrolase 1, 
pyruvate dehydrogenase and cofilin-1. Downregulated proteins were MAP 
kinase kinase 1 (MEK 1), neuron-specific calcium-binding protein hippocalcin, 
dihydropyrimidinase-related protein 2 (DRP-2), guanine deaminase, neuronal 
protein NP25 (Transgelin-3), ATPase, ADP-ribosylarginine hydrolase, 
vacuolar ATP synthase, transferrin, creatine kinase and eukaryotic translation 
initiation factor 5A-1. The proteins were also grouped into functional groups 
(see Table 2, figure 3a and 3b). 
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Table 2: Data represents the differentially expressed proteins between control 68 and TDS 68 animals. Only those proteins whose 
concentrations changes significantly are reported (p ≤ .05, T-test). The SSP number is assigned by PDQuest software.   
 
 
 
 
 
Mr (Da) pI MASCOT 
score 
Protein name Swiss Prot 
Accession 
Number 
% Sequence 
Coverage 
No of peptides Fold increase 
or decrease 
Functional group 
5403 43648 6.20 82 MAP kinase kinase 1 
(MEK 1)
Q01986 13% 4 -3.35 Ca2+ homeostasis 
/ signaling 
1002 22396 4.87 
 
52 Neuron-specific calcium-
binding protein 
hippocalcin 
P84076 4% 1 -1.81 Ca2+ homeostasis 
/ signaling 
5702 62638 5.95 
 
243 Dihydropyrimidinase-
related protein 2 (DRP-2)
P47942 18 8 -2.01 neuroplasticity 
4502 51554 5.56 547 Guanine deaminase Q9WTT6 41% 17 -1.29 neuroplasticity 
8004 22627 6.84 265 Transgelin-3 (Neuronal 
protein NP25)
Q9R1Q8 41% 10 -1.51 cytoskeleton 
0002 15499 5.06 68 Complexin -2 (Synaphin-
1)
P84087 19% 4 2.00 vesicular docking 
and fusion 
6002 18618 8.26 153 Cofilin-1 P45592 46% 5 1.26 cell cycle 
4803 68700 5.41 239 similar to ATPase 
(predicted from NCBI 
Blast sequence search) 
P31404 
(Bovine) 
22% 
 
9 -2.23 energy 
metabolism 
4303 40220 5.53 49 ADP-ribosylarginine 
hydrolase
Q02589 9% 3 -1.50 energy 
metabolism 
3803 68567 5.62 169 Vacuolar ATP synthase P50516 10% 5 -4.74 energy 
metabolism 
3305 39336 5.94 344 Pyruvate dehydrogenase P49432 31% 13 1.57 energy 
metabolism 
4401 42970 5.33 
 
583 Creatine kinase P07335 55% 22 -1.56 energy 
metabolism 
1003 16918 5.08 
 
135 Eukaryotic translation 
initiation factor 5A-1
Q3T1J1 33% 7 -1.19 cell proliferation 
2102 25165 5.14 
 
228 Ubiquitin carboxyl-
terminal hydrolase 1 
(Ubiquitin thioesterase)
Q00981 55% 8 1.47 protein 
degradation 
8801 78538 6.94 119 Transferrin P12346-00-00-
00 
6% 
 
4 -1.67 iron transport 
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Figure 3a: Representative 2D SDS PAGE image of significantly differentially 
expressed proteins. SSP 1002: Hippocalcin; SSP 0002: Synaphin-1; SSP 
8004: Neuronal protein NP25. Red histograms represent traumatized animals 
and green histograms controls, each sample run in triplicate.  
 
   
 
Figure 3b: Representative image of differential expression of Synaphin-1 
(SSP 0002) between control 68 (left) and TDS 68 (right) animals. Synaphin 
shows a 2-fold increase in traumatized animals relative to control (see table 
2).         
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Discussion 
 
Clinical studies suggest that early life trauma may cause behavioural 
abnormalities later in life (Heim and Nemeroff, 2001; Kendler et al., 1992). 
However the underlying molecular mechanisms responsible for mediating the 
effects of the trauma, remains unclear. Using an animal model we are able to 
show that trauma during adolescence combined with adulthood re-stress 
affects a multitude of different cellular systems that include cytoskeletal, cell 
cycle, transcription, cell signaling, neuroplasticity and apoptotic proteins.   
 
A number of indicators of cell dysfunction have been investigated in the 
present study. For instance the levels of S-100B, a member of the S100 family 
of EF-hand Ca2+-binding proteins,  are increased in the serum of both 
neurological patients that suffered an ischemic stroke, as well as psychiatric 
patients diagnosed with schizophrenia and major depression (Rothermundt et 
al., 2003). Interestingly, animal studies of prenatal stress have also showed 
increased serum levels of S-100B in adulthood (Barros et al., 2006). It has 
also been demonstrated that S-100B can be neuroprotective against NDMA-
induced neurotoxicity in cultured rat hippocampal neurons (Kogel et al., 2004). 
This neuroprotection apparently resulted from the ability of S-100B to regulate 
Ca2+ homeostasis. Similar to prenatally stressed rats, animals subjected to 
trauma also displayed elevated S-100B levels compared to controls – a 
finding that we confirmed with Western Blot analysis. It is therefore likely that 
this increase in S-100B may result from raised Ca2+ concentrations in the 
neurons and/or astrocytes (Tramontina et al., 2006, Xiong et al., 2000).  
 
Proline-rich tyrosine kinase 2 (Pyk2) is a non-receptor tyrosine kinase and is 
activated upon NMDA receptor stimulation (Alier and Morris, 2005). Pyk2 
phosphorylation is increased after NMDA receptor stimulation and this 
increase is blocked by the PKC inhibitors, chelerythrine or staurosporine (Alier 
and Morris, 2005). In our experiments, trauma caused an increase in 
phosphorylated Pyk2, and this observation strengthens our hypothesis of 
stress-induced Ca2+ influx via NMDA receptors.   
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Hippocalcin is a Ca2+ binding protein in the hippocampus. Hippocalcin 
deficient mice show elevated levels of Caspase-12 (Korhonen et al., 2005), 
which is in agreement with the increase found in our traumatized animals. In 
addition high intracellular Ca2+ levels causes hippocalcin to translocate to the 
membrane (Oh et al., 2006), which may explain the decrease in the cytosolic 
extract sample of traumatized animals subjected to trauma.  
 
Since Ca2+ is central to a number of intracellular signaling pathways, 
fluctuations in its concentration ought to translate into changes in the activity 
and expression of many other proteins. It was therefore not surprising to 
observe alterations in the levels of signaling proteins, especially those 
involved in stress-related responses. As such we report an increase in 
phospho- c-Jun N-terminal kinases (JNK’s) expression in traumatized 
animals. JNK’s are also called stress activated protein kinases and are part of 
the mitogen-activated (MAP) kinase family (Mielke and Herdegen, 2000). Both 
cytoplasmic and nuclear proteins can be phosphorylated by JNK’s. These 
include neurofilament heavy chain (Giasson and Mushynski, 1997), Bcl-2 
(Park et al., 1997), glucocorticoid receptors (Rogatsky et al., 1998) and c-Jun 
(Behrens et al., 1999). The increase in phospho-JNK, such as observed after 
trauma, once again reflect cellular stress. This is particularly plausible since 
we have previously shown a decrease in glucocorticoid receptors in 
traumatized animals (Uys et al., 2006b), possibly stemming from increased 
inhibition of its transcription by the JNK levels (Rogatsky et al., 1998). In 
addition we also found a decrease in MAP kinase kinase (MEK 1). This may 
point to an impairment in the cell’s ability to transduce cell survival signals, 
since MEK inhibitors block NGF-induced neuroprotection after glutamate 
excitotoxicity (Singer et al., 1999).  
 
Finally, the elevation in calcineurin further suggests that activity of Ca2+ 
mediated signaling has been enhanced in traumatised rats. This is in 
agreement with studies where animals subjected to chronic social stress, with 
impairment in long-term potentiation in the hippocampus, show higher basal 
levels of calcineurin (Gerges et al., 2004). Furthermore, calcineurin is also 
increased by S-100B in a Ca2+-dependent manner (Leal et al., 2004). 
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Calcineurin (protein phosphatase 2B), is however also involved in neuronal 
plasticity (Groth et al., 2003) and so it was anticipated that changes in the 
expression of proteins participating in processes important for neural 
plasticity, would be present in rats subjected to trauma.  
 
The protein, ARF nucleotide binding site opener (ARNO), which is a member 
of the ADP-ribosylation factor (ARF) family of small GTPases, is a regulator of 
dendritic branching in the hippocampus. It is present in both the embryonic 
and adult hippocampus and is upregulated during early dendritogenesis 
(Hernandez-Deviez et al., 2002). A down-regulation in ARNO levels is 
observed and this suggests impairment in dendritogenesis in traumatized 
animals. Similarly the Abl non-receptor tyrosine kinases family regulates cell 
morphogenesis and neuronal axonal development through interaction with the 
actin cytoskeleton (Gertler et al., 1995). Abl also modulates synaptic plasticity 
and neurotransmitter release in the hippocampus (Moresco et al., 2003). In 
addition, inhibition of Abl kinases decreases dendritic branching in 
hippocampal neurons (Jones et al., 2004). DRP-2 is important for guidance of 
axonal outgrowth and interacts with collapsin, which is responsible for 
dendritic guidance (Lubec et al., 1999). A decrease in DRP-2 could result in 
shortened dendrites and impairment in axonal innervation.  A decrease in 
guanine deaminase activity, such as seen in trauma, is associated with 
impaired dentritic branching (Akum et al., 2004).  
The decrease in guanine deaminase, DRP-2 and c-Abl caused by trauma is 
therefore aligned with the notion of reduced dendritogenesis and/or 
problematic short term synaptic plasticity.  
 
Furthermore, under normal conditions Abl kinase activity is increased by 
integrin receptor engagement (Lewis et al., 1996). Another explanation for the 
reduced expression of c-Abl in the present study could be due to the increase 
in serine phospho-FAK (focal adhesion kinase) observed in traumatized rats. 
Focal adhesions link the extracellular matrix with the actin cytoskeleton and 
therefore control cell morphology (Yamakita et al., 1999). In addition, focal 
adhesions also play a role in integrin-mediated signal transduction. When FAK 
becomes phosphorylated on serine residues, there is a dephoshorylation on 
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tyrosine residues. This leads to the dissociation of the FAK/CAS/c-Src 
signaling complex and eventual integrin signaling arrest (Yamakita et al., 
1999). Loss of integrin signaling has been associated with a specific type of 
apoptosis called anoikis (Frisch and Francis, 1994). Therefore in traumatized 
animals an increase in phospho-serine-FAK not only lead to disrupted neural 
plasticity but also to anoikis.  Additional support for apoptotic pathways to be 
switched on following trauma, comes from data showing increased levels of 
caspases -9, -10 and -12. These cysteine proteases function as initiators of 
apoptosis and activate downstream executioners such as caspases -3, -6, 
and -7 (Riedl and Shi. 2004). 
 
One of the major consequences of trauma is to disturb the integrity of the 
cytoskeleton of neurons. Tubulins are cytoskeletal proteins which aid in the 
growth and regulation of axons and dendrites. These extend from the cell 
body and give neuronal cells their asymmetrical morphologies. There are 
numerous α- and β-tubulin isoforms present which can also be post-
translationally modified (Audebert et al., 1994). Polyglutamylation is the 
addition of 1-6 glutamyl units on the side chain of a glutamate residue near 
the carboxy terminus of either alpha or β-tubulin (Rudiger et al., 1992). This 
post-translational modified form of β-Tubulin is increased in neurons during 
differentiation (Audebert et al., 1994). Since trauma caused a decrease in 
polyglutamylated β-Tubulin, this may point to a decrease in neuronal 
differentiation.  
 
Additional evidence relating to changes in important cytoskeletal components 
is seen in the increase in the concentration of desmin and cytokeratin in 
traumatized animals. Together with glial fibrillary acidic protein and vimentin, 
these proteins form intermediate neurofilaments in neurons. Changes in 
desmin and cytokeratin levels are therefore likely to indicate alterations in 
neuron structure, and this may contribute to cell nuclear fragmention and cell 
death (Yu et al., 1994).  Large neuronal filaments (NFP) on the other hand are 
regulators of axonal transport. They can be divided into 200 kDa, 160 kDa and 
68 kDa subunits respectively. Functional filaments are usually 
phosphorylated. Interestingly, Ca2+ overload induced a decrease in phospho-
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NFP in the CA1 subfield and dentate gyrus of hippocampus of spontaneously 
hypertensive rats and these rats have increased susceptibility to ischemic 
damage (Sabbatini et al., 2001). It seems therefore that the reduced level of 
neurofilament 200 in traumatized rats is yet another indicator of neuronal 
stress. 
 
Neuronal protein NP25 is a major interactor with actin and co-localizes with F-
actin (Mori et al., 2004a). This interaction may be particularly important for 
reorganization during neuronal differentiation and normal neural development 
(Mori et al., 2004a). Furthermore, NP25 is increased during NGF 
differentiation of PC12 cells (Mori et al., 2004b). The decrease in NP25 in 
traumatized animals, together with the decrease in the growth factors, BDNF 
and NT-3 (Uys et al, 2006a), may point to an impairment in neuronal 
differentiation and actin stability of the cytoskeleton.   
 
Syntaxin is a membrane protein, primarily expressed in neuronal tissue. It is 
predominantly responsible, together with synaptophysin and synapsin, for 
synaptic vesicle docking or fusion in the active zone of the presynaptic plasma 
membrane (Brose, 1993). Increases in the concentration of syntaxin have 
been observed in the frontal and temporal cortex of patients suffering from 
Alzheimer’s disease (Mukaetova-Ladinska et al., 2000). Another protein 
associated with syntaxin, synaphin 1 (also called complexin II) (Ishizuka et al., 
1999) was found to be increased in traumatized animals. Elevations in 
vesicular/docking proteins can therefore be associated with abnormal brain 
function. 
 
The expression of MAP-1b, a structural protein, is significantly increased in 
animals subjected to trauma. Normally MAP-1b is expressed in high 
concentrations in the mossy fiber region of the hippocampus of the new born 
brain and then its level decreases with development (Schoenfeld et al., 1989). 
It has been shown that upregulation of MAP-1b occurs in the surrounding 
viable neurons of the infarct zone after cerebral ischemia (Popa-Wagner et al., 
1999), suggesting a regenerative function of the protein. Interestingly the 
upregulation was greater in young rats than older animals (Popa-Wagner et 
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al., 1999). The increase in MAP-1b in our animals may therefore similarly 
reflect the activation of recovery mechanisms in the brain’s attempts to 
combat the deleterious effects of the trauma. 
 
The deleterious effects of trauma are not limited to signaling pathways and 
cytoskeletal proteins, but include regulators of the cell cycle. For instance 
Cdc25C and chk 1 expression are decreased and increased respectively. 
Cdc25C plays an important role in cell proliferation and cell cycle arrest. 
Inhibition of lung cancer cell growth by means of cell cycle arrest and 
apoptosis, was accompanied by reduced levels of Cdc25C and increased 
levels of c-Jun-N-terminal kinase (JNK) (Hsu et al., 2006). In addition, a 
decrease in Cdc25C and an increase in Chk1 were seen in malignant 
transformed Syrian hamster embryo cells by Malachite green (Ashra and Rao, 
2005). This transformation of embryoninc cells was also associated with DNA 
damage and cycle cycle arrest. Alterations in the expression of other 
members of the cell cycle control machinery have also been obtained to 
support a claim of overall suppression of cell division. For example Cdk6, a D-
cyclin associated kinase, play an important role in cell cycle control and cell 
division (Ericson et al., 2003). In addition, cdk7 with cyclin H and the assembly 
factor MAT1, together known as the CDK activating kinase (CAK) complex, 
are responsible for activating cdk6 (Lolli and Johnson, 2005). Both cdk6 
(Costello et al., 1997) and cdk7 (Bicaku et al., 2005) have been found in 
human glioma cells and may play a role in transcription (Fisher, 2005). Finally, 
overexpression of cofilin, a regulator of cell motility via the actin cytoskeleton, 
leads to impaired cell motility and G1 phase cell cycle arrest (Lee et al., 2005).    
It may therefore be possible that the higher levels of cofilin together with the 
lower levels of cdk6 and cdk7 in traumatized animals are added markers of 
cell cycle arrest.  
 
The above-mentioned proteins are not the only cell cycle proteins affected by 
trauma. Down-regulation of p16, a member of the INK4 family of proteins and 
an inhibitor of the cdk’s (Sherr and Roberts, 1999), has been noted. While the 
INK4 family only binds to cdk4 and cdk6 and not to other cdk’s or to D-type 
cyclins, the Kip family affects cyclin D-, E-, and A-dependent kinases (Sherr 
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and Roberts, 1999). More specifically, they are inhibitors of cyclin E- and A-
dependent kinases and positive regulators of cyclin D-dependent kinases. 
p57Kip2, which is required for normal development, and the overexpression 
thereof causes G1 phase arrest (Matsuoka et al., 1996), is upregulated after 
trauma. Similarly the expression of p34 (Cdc2), a cyclin B-dependent kinase is 
elevated in traumatized rats. Cdc2 catalyzes the phosphorylation of the 
protein BAD at serine 128. This results in BAD-induced apoptosis and inhibits 
the ability of growth factors to stop the apoptotic effect (Konishi et al., 2002). 
The increase in Cdc2 coupled with the upregulation in caspases 9, 10 and 12 
(see earlier) and the decreased levels of the growth factors, BDNF and NT-3 
in the ventral hippocampus (Uys et al., 2006a) strongly substantiates a 
condition of increased cellular stress leading to cell cycle arrest. 
 
The effects of trauma have been so widespread that even nuclear structure 
and activity are altered. c-Myc is a transcription factor important in the 
regulation of both cell proliferation and cell death (Shervington et al., 2006). 
Even though c-Myc progresses the cell cycle from G1 phase to S phase, it 
also induces apoptosis when expressed under growth inhibitory conditions, 
such as lack of growth factors (Packham and Cleveland, 1995). As this is the 
case in traumatized animals (Uys et al., 2006a), the elevation in c-Myc levels 
further suggests a pro-apoptotic mode in which the cells may occur. Histones 
are proteins involved in the packaging of DNA into nucleosome units. 
Acetylation of the lysine residues on histones is associated with transcriptional 
activation and results in a remodeling of the nucleosome (Kornberg and 
Lorch, 1999). In addition, increased levels of histone acetylation in primary 
neurons, decreases the onset of apoptosis (Rouaux et al., 2003). The 
increase in acetylated histone 3 by trauma could therefore be a reaction by 
the cell to prevent and/or minimize apoptosis.  
 
A number of energy metabolism ezymes are also dysregulated following 
trauma. These included ATPase, ADP-ribosylarginine hydrolase, vacuolar 
ATP synthase, pyruvate dehydrogenase and creatine kinase. This may reflect 
a general dysfunction of the cell and inability to supply adequate energy to 
function optimally.   
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In summary, subjection of adolescent rats to trauma results in extensive 
deleterious consequences. It remains to be investigated whether these effects 
occur within projection or interneurons. Our data suggests that the trauma 
caused prolonged NMDA receptor activation, leading to sustained (but not 
lethal) increases in intracellular Ca2+ concentrations. Because of its central 
role in cell function, a number of physiological systems are disturbed by the 
continuous elevation. Subsequently signaling pathways are dysregulated, the 
overall structure of the cell is disrupted, and apoptotic mechanisms are 
initiated. The fact that the animals are able to survive suggests that 
compensatory mechanisms which counter this death penalty are still in place 
and therefore prevent large scale cell death in the brain. These effects may 
occur in neurons and/or glial cells. However, the balance between these two 
opposing systems is tilted towards aberrant brain function as traumatized rats 
display abnormal behaviour (Uys et al., 2006a).  
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Chapter 9 
General Conlusion 
 
 
This study focused on the effects of early life trauma in adulthood. This was 
explored on a behavioural, neuroendocrinological and proteome level.  
 
Animals subjected to adolescent trauma showed an increase in basal 
corticosterone levels and a decrease in glucocorticoid receptors in the dentate 
gyrus 24 hours after adulthood re-stress (PND 61) (Chapter 3). These effects 
were reversed by pre-treatment with the SSRI, escitalopram. In addition, there 
were no changes in NGF, BDNF or NT-3 at this timepoint (Chapter 4). 
Decreases in BDNF in the dorsal and in NT-3 in the dorsal and ventral 
hippocampus were evident 8 days post re-stress (PND 68), with an increase 
in basal corticosterone levels and behavioural hyperarousal (Chapter 5). The 
changes in neurotrophins were not accompanied by changes in plasma BDNF 
or NT-3 levels or PI-3 kinase, PKB, PTEN or phospho-Forkhead expression in 
the dorsal and ventral hippocampus (Chapter 6).  
A number of cell cycle-, signaling-, plasticity- and apoptotic proteins were up- 
or down regulated in the ventral hippocampus on PND 68 (Chapter 8).  
 
We propose that adolescent trauma causes an increase in corticosterone 
levels which leads to down regulation of GC receptors, possible through JNK 
mediated inhibition of GC receptor transcription. The trauma-induced down 
regulation of GC receptors causes basal corticosterone levels to stay elevated 
by a decrease in negative feedback inhibition. It has been proposed that an 
increase in glucorticoids may damage neurons through a NMDA receptor 
dependent mechanism and increase stress-induced neuronal susceptibility to 
subsequent insults (Armanini et al., 1990). Indeed, high levels of 
corticosterone in rat hippocampal neurons, caused a rapid and prolonged 
elevation of Ca2+ through NMDA receptors, which resulted in Ca2+ induced 
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neurotoxicity (Takahashi et al., 2002). The decrease in BDNF and NT-3 on 
PND 68 may contribute the cell’s susceptibility to subsequent stressors. 
These effects, together with the loss of integrin signaling and an increase in 
caspase initiator proteins, indicate that the brain of traumatized rats are in a 
state of pro-apoptosis, specifically anoikis. In addition a number of cell cycle 
arrest proteins are upregulated. Cell cycle arrest during G1/S phase provides 
resistance to anoikis (Collins et al., 2005). The parallel processes of the cell to 
avoid anoikis on one hand and inducing a state of cell cycle arrest on the 
other, is probably a biological coping mechanism to avoid transcription of sub-
standard cellular features.   
 
This study showed that adolescent trauma caused a number of changes on 
behavioural and cellular level. In addition, it highlights the complexity of 
behavioural-cellular interactions and underlies the necessity to study multi-
parameters if one is to understand intricate pathologies such as mood and 
anxiety disorders. Finally, the study demonstrated that proteomic technologies 
provide us with tools to investigate complicated disease states in a more 
holistic manner.  
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